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ABSTRACT OF DISSERTATION

THE ROLE OF ENDOPLASMIC RETICULUM STRESS IN ETHANOL-INDUCED
NEURODEGENERATION
Heavy ethanol use causes neurodegeneration manifested by neuronal loss and
dysfunction. It is becoming imperative to delineate the underlying mechanism to promote
the treatment of ethanol-induced neurodegeneration. Endoplasmic reticulum (ER) stress is
a hallmark and an underlying mechanism of many neurodegenerative diseases. This study
aims to investigate the role of ER stress in ethanol-induced neurodegeneration. In
experimental design, adult mice were exposed to binge ethanol drinking by daily gavage
for 1, 5, or 10 days and the response of ER stress was examined. We found the induction
of ER stress appeared at 5 days and remained at 10 days. Moreover, the induction of ER
stress was accompanied by an increase in neurodegeneration. With cell culture, we
demonstrated that ethanol exposure resulted in neuronal apoptosis and that blocking ER
stress by sodium phenylbutyrate (4-PBA) abolished ethanol-induced neuronal apoptosis,
suggesting that ER stress contributes to ethanol-induced neurodegeneration.
Mesencephalic astrocyte-derived neurotrophic factor (MANF) responds to ER
stress and has been identified as a protein upregulated in ethanol-exposed developmental
mouse brains. To investigate its implication in ethanol-induced neurodegeneration, we
established a central nervous system (CNS)-specific Manf knockout mouse model and
examined the effects of MANF deficiency on ethanol-induced neuronal apoptosis and ER
stress using a third-trimester equivalent mouse model. We found MANF deficiency
worsened ethanol-induced neuronal apoptosis and ER stress and that blocking ER stress
abrogated the harmful effects of MANF deficiency on ethanol-induced neuronal apoptosis.
Moreover, a whole transcriptome RNA sequencing supported the involvement of MANF
in ER stress modulation and revealed candidates that may mediate the ER stress-buffering
capacity of MANF. Collectively, these data suggest that MANF is neuroprotective against
ethanol-induced neurodegeneration via ameliorating ER stress.
Because MANF is a neurotrophic factor, we also examined the effects of MANF
deficiency on neurogenesis. We observed that MANF deficiency increased neurogenesis

in the subgranular zone of the hippocampal dentate gyrus and subventricular zone of the
lateral ventricles in the mouse brain. Mechanistically, this finding was supported by a
decrease of cell cycle inhibitors (p15 and p27), an increase of G2/M marker (phosphohistone H3), and an increase of neural progenitor markers (Sox2 and NeuroD1) in the brain
of conditional Manf knockout mice. Our in vitro studies demonstrated that the gain-offunction of MANF inhibited cell cycle progression, whereas the loss-of-function of MANF
promoted cell cycle progression. Taken together, these data suggest that MANF may affect
the process of neurogenesis through altering cell cycle progression.
KEYWORDS: ER Stress, Ethanol-induced Neurodegeneration, Neurogenesis,
Mesencephalic Astrocyte-derived Neurotrophic Factor
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CHAPTER 1. INTRODUCTION
1.1
1.1.1

Concepts and Definitions Related to Ethanol Use
Standard Drink
In the United States, one standard drink contains roughly 14 grams of pure ethanol.

This amount of ethanol content is equal to (1) 12 ounces of regular beer, (2) 5 ounces of
wine, or (3) 1.5 ounces of distilled spirits [1].
1.1.2

Moderate Ethanol Drinking
According to the “ Dietary Guidelines for Americans 2015-2020,” U.S. Department

of Health and Human Services and U.S. Department of Agriculture, moderate drinking was
defined as up to 1 drink per day for women and up to 2 drinks per day for men [2].
1.1.3

Drinking at Low Risk
For women, low-risk drinking is considered as no more than 3 drinks on any single

day and no more than 7 drinks per week. For men, it is considered as no more than 4 drinks
on any single day and no more than 14 drinks per week [2]. Research from the National
Institute on Alcohol Abuse and Alcoholism (NIAAA) suggested that about 2 per 100
people drinking within these limits developed alcohol use disorder [2].
1.1.4

Binge Drinking and Heavy Alcohol Use
According to NIAAA, binge drinking is defined as a drinking pattern that brings

BEC levels to 0.08g/dL. It typically occurs after having 4 drinks for women and 5 drinks
for men within 2 hours. The Substance Abuse and Mental Health Services Administration
(SAMHSA) conducts National Survey on Drug Use and Health annually, and defines binge
drinking as 5 or more alcoholic drinks for males or 4 or more alcoholic drinks for females
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on the same occasion, i.e., within a couple of hours of each other, on at least one day in the
past month [2].
SAMHSA defines heavy alcohol use as a drinking pattern of having binge drinking
for no less than 5 days in the past month [2].
1.1.5

Alcohol Use Disorder (AUD)
AUD, also called alcoholism, is a brain disease, manifested by compulsive ethanol

use and loss of control of ethanol intake despite the knowledge of adverse social,
occupational, and health consequences. Prior to the fifth edition of the Diagnostic and
Statistical Manual (DSM-V), ethanol abuse and ethanol dependence were regarded as two
ethanol-related disorders. They were integrated into a single disease called alcohol use
disorder or AUD in DSV-V. To be diagnosed as AUD, patients must meet at least two of
the 11 criteria that are outlined in the DSM-V. AUD can range from mild to severe, based
on the number of features present [3].
1.1.6

Fetal Alcohol Spectrum Disorders (FASDs)
FASDs is an umbrella term that includes fetal alcohol syndrome (FAS), partial fetal

alcohol syndrome (pFAS), alcohol-related neurodevelopmental disorder (ARND), and
alcohol-related birth defects (ARBD). FASDs are characterized by damage to the central
nervous system; the damaged CNS is coupled with cognitive dysfunction and behavioral
changes [4].
1.1.7

Wernicke-Korsakoff Syndrome (WKS)
WKS is a type of brain disorder, manifested by the combined presence of Wernicke

encephalopathy and alcoholic Korsakoff syndrome, due to thiamine (vitamin B1)
deficiency. Symptoms of WKS may include confusion, unsteady stance, and impaired
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memory and cognition. Chronic ethanol misuse and malnutrition can cause thiamine
deficiency and are the most common causes of WKS [4].
1.1.8

Disability-Adjusted Life Years (DALYs)
DALYs are expressed as the number of years lost due to unhealthy conditions. The

sum of these DALYs in the population is a measure of overall disease burden in society,
reflecting the gap between current health status and an ideal health situation, namely, free
of disease and disability [4].
1.2

Overview of Ethanol Consumption
People drink to socialize, celebrate, or relax. In many of today’s societies, alcoholic

beverages are a routine part of the social landscape. A global status report on ethanol and
health, published by the World Health Organization (WHO) in 2018, outlined ethanol
consumption worldwide and the drinking patterns and trends since 2000 [4]. First, the
prevalence of drinking and total ethanol per capita consumption has declined in some WHO
regions, e.g., European regions, but has increased in other WHO regions, e.g., Western
Pacific Region since 2000 [4]. Thus, the prevalence of drinking and total ethanol per capita
worldwide, in general, remained stable since 2000. Secondly, binge drinking, defined as
having more than 4 drinks for women or 5 drinks for men on one occasion at least once per
month, was prevalent among drinkers and was particularly popular among young people
and college students [4]. Thirdly, in all WHO regions, females drank less and were less
often current drinkers than males. However, the absolute number of current women
drinkers has increased in the world [4]. Lastly, the economic wealth of a region correlates
with higher ethanol consumption and the prevalence of current drinkers, and the incidence
of drinking and total ethanol per capita was projected to increase in the future [4].
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Ethanol consumption has effects on people, and these effects vary from person to
person depending on a variety of factors, namely: (1) how much you drink; (2) how often
you drink; (3) how early you are exposed to ethanol drinking; (4) health status; and (5)
family history or genetic variety. In general, drinking at a mild or moderate level is not
necessarily a problem [5]; however, drinking too much can cause a range of severe
consequences [4]. In 2016, the harmful use of ethanol caused 3 million death, amounting
to 5.3% of all death worldwide and 132.6 million disability-adjusted life years (DALYs),
accounting for 5.1% of all DALYs in that year [4]. The mortality due to ethanol use was
higher than that caused by diseases such as tuberculosis, HIV/AIDS, and diabetes [4]. Of
all the deaths due to ethanol use, 28.7% were due to injuries; 21.3% were due to digestive
diseases; 19% were due to cardiovascular diseases; 12.9% were due to infectious diseases;
12.6% were due to cancers [4]. About 49% of ethanol-attributable DALYs were related to
non-communicable and mental conditions, and about 40% were due to injuries [4]. An
estimate of 237 million men and 46 million women had AUD, with the highest prevalence
of AUD among men and women in the European Region [4]. Besides, long-term ethanol
use may cause a deficiency of thiamine in people, resulting in WKS, a brain disease due to
a lack of thiamine [4].
The harms due to ethanol use affected not only the drinkers, but also those people
around him or her, e.g., others in the family, relatives, and friends, or strangers encountered
on the street. For instance, the drinker may cause injury, or anxiety or depression to family
members or pass infectious diseases to sexual partners. Beyond health consequences, the
harm resulted from drinking may also be social, e.g., assault, community nuisance, or
economic, e.g., damage to property or money for family necessities [4].
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1.3

Ethanol Use in the United States
A National Survey on Drug Use and Health (NSDUH) was conducted annually in

the United States. NSDUH asked respondents aged 12 and older about their ethanol use in
the lifetime, in the past year or the past month. The data were classified by age groups and
further sub-classified into different groups according to the drinking pattern or the
quantities consumed, e.g., binge drinking or heavy alcohol use. The legal drinking age, in
the United States, is 21. Drinking at an age below 21 is viewed as underage drinking.
1.3.1

Ethanol Use in Adult
According to the survey in 2015, about 209.8 million people aged 18 and older,

representing 86.4% of this age group, reported that they drank ethanol at some point in
their lifetime; About 170.2 million people aged 18 and older, representing 70.1% of this
age group, said that they drank at some point in the past year; About 136.0 million people
aged 18 and older, representing 56% of this age group, said that they drank at some point
in the past month [6]. About 65.2 million people aged 18 and older, representing 26.9% of
this age group, reported that they were engaged in binge drinking at least once in the past
month; About 17.1 million people aged 18 and older, representing 7.0% of this age group,
reported that they were involved in heavy drinking in the past month [7].
1.3.2

Underage Ethanol Use
According to the 2015 NSDUH, 33.1% of 15-year-old teenagers reported that they

had at least one drink in their lives. About 7.7 million people aged between 12 and 20,
representing 20.3% of this age group, reported that they drank ethanol at some point in the
past month. That included 19.8% of males and 20.8% of females [8-10]. About 5.1 million
people, representing 13.4% of people aged between 12 and 20, said that they had binge

5

drinking at least once in the past month. That included 13.4% of males and 13.3% of
females [9, 10]. Approximately 1.3 million people, representing 3.3% of teenagers aged
between 12 and 20, reported that they are involved in heavy alcohol use in the past month.
That included 3.6% of males and 3.0% of females [9, 10].
1.3.3

Ethanol Use in College Students
According to the 2015 NSDUH, 58.0% of full-time college students aged between

18 and 22 said they drank ethanol at least once in the past month compared to 48.2% of
other persons of the same age [11]. 37.9% of college students aged between 18 and 22
reported that they were engaged in binge drinking in the past month compared to 32.6% of
other persons of the same age [11]. 12.5% of college students aged between 18 and 22
reported that they were involved in heavy alcohol use compared to 8.5% of other persons
of the same age [11].
1.4

Health Consequences due to Ethanol Use
Excessive ethanol consumption affects the functionality of multiple organs such as

the brain, heart, pancreas, and liver, causing severe health consequences. Around 88,000
people, including 62,000 men, and 26,000 women, died from ethanol-related diseases
annually, making ethanol the third leading preventable cause of death in the United States
after tobacco and poor diet and physical inactivity [12]. About 19,500 deaths, representing
3.5% of all cancer deaths, were attributed to ethanol consumption in 2009. The National
Toxicology Program of the US Department of Health and Human Services even listed
ethanol as a human carcinogen [13]. Recently, ethanol use has also been shown to increase
the risk of HIV infection and transmission. The significant impacts that ethanol
consumption has on health have been depicted and summarized in this section [13].
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1.4.1

Infectious Diseases
HIV/AIDS
Ethanol use has been recently demonstrated to increase the risk of HIV/AIDS [14].

It is associated both with an increase of risk of acquiring HIV infection and with the
negative results in terms of treatment, morbidity, and mortality of patients with HIV [14].
The harmful use of ethanol has an impact on HIV infection and transmission mainly in
three ways. First, ethanol consumption increases the risk of HIV transmission, notably
through engaging in risky sexual behaviors such as multiple sexual partnerships or
inconsistent condom use [15]. Secondly, ethanol intake has adverse effects on HIV
treatment due to ethanol-and-drug interaction, an increase of resistance to antiretroviral
medications, or failure in following treatment plans [16]. Lastly, ethanol drinking can
weaken the immune system, making it susceptible to infection and disease progression
[17].
In 2015, the U.S. Centers for Disease Control and Prevention (CDC) reported that
in the United States, 39,513 people were diagnosed with HIV infection. More than 1.2
million people were HIV carriers in the United States, and 1 in 8 of them was unaware of
that [18]. The data from epidemiological research showed that ethanol misuse contributed
to the spread of HIV and hurt the treatment of infected patients.
Tuberculosis (TB)
Ethanol use, especially heavy ethanol intake, is associated with an increase in the
risk of tuberculosis infection. On the one hand, ethanol consumption can suppress the
immune system, making it amenable to active tuberculosis [19]; on the other hand, ethanol
consumption can impact the absorption and metabolism of tuberculosis drugs, causing
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hepatotoxicity-a common side effect of tuberculosis medications [20]. People with alcohol
use disorders are at higher risk of poor treatment adherence and treatment failure of
tuberculosis infection.
In 2017, a total of 9,105 TB cases were reported, and the national incidence rate
was 2.8 cases in 100,000 persons in the United States. With patient samples spanning from
1997 to 2012, a meta-analysis study showed that excessive ethanol use was associated with
TB transmission and high mortality [21].
1.4.2

Non-communicable Diseases
Cardiovascular Diseases
There is increasing evidence showing that ethanol consumption is associated with

the occurrence of cardiovascular diseases [22]. For instance, a high amount of ethanol
consumption has been shown to increase the risk of high blood pressure [23],
cardiomyopathy [24], arrhythmias [25], and strokes [26]. Scientists found the onset of
ischemic heart diseases and strokes was associated with a high volume of ethanol intake
and irregular drinking patterns; people with low-to-moderate ethanol consumption had a
significantly lower disease risk [22, 27].
Cancers
It has been well established that ethanol consumption is not only linked with the
occurrence of cancer but also associated with the progression of cancer. Types of cancer
that are associated with ethanol drinking include oropharynx, larynx, esophagus, liver,
colon, rectum, and breast cancer [28]. People who drink 50 or more grams of ethanol have
a higher risk of developing head and neck cancer by two or three times. Even moderate
ethanol intake, e.g., 25 grams of pure ethanol, has been shown to increase the risk of
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developing breast cancer [28]. More importantly, tobacco use has been shown to increase
the risks of ethanol-associated cancer.
Several mechanisms are believed to be responsible for the occurrence and
progression of cancer resulted from ethanol consumption. Ethanol has been shown to cause
DNA strands damage, and impair DNA repair processes primarily through the intermediate
metabolite–acetaldehyde. Ethanol use is also linked with the defect of one-carbon
metabolism, resulting in nutritional deﬁciencies and defects of DNA replication [29].
Ethanol has also been shown to modulate estrogen pathways, thereby increasing the risk of
developing breast cancer in females [30].
Liver Diseases
Heavy drinking causes a variety of liver diseases such as steatosis, alcoholic
hepatitis, fibrosis, and cirrhosis. Acute alcoholic hepatitis and liver cirrhosis are associated
with high mortality; the median survival time of patients with advanced liver cirrhosis or
acute alcoholic hepatitis can be as low as 1–2 years [31]. The causal relationship between
ethanol consumption and liver diseases has been well established; ethanol consumption
can cause hepatocellular damage due to malnutrition or mechanisms related to ethanol
metabolism [32]. Of all cirrhosis deaths in 2013, 47.9% of those were attributable to
ethanol consumption. Almost 1 in 3 liver transplants in the United States in 2009 were due
to ethanol-related liver diseases [3].
1.4.3

Ethanol and Mental Health
Intoxication
Ethanol is a psychoactive substance, generating motivation and desire for

rewarding stimuli or pleasurable feelings through reinforcing dopamine and
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norepinephrine neurotransmitter system. Meanwhile, ethanol, by facilitating GABAergic
transmission and inhibiting glutamatergic transmission, is also a central nervous system
depressant, which is accountable for ethanol intoxication. The effects of ethanol
intoxication are dependent on BEC and are shown by various psychological and behavioral
manifestations. In general, a low level of BEC causes poor coordination and loss of
attention that is associated with driving accidents; higher level of BEC results in ataxia,
poor judgment, and disinhibition of behavioral control that are associated with aggression
and crime violence; extreme level of BEC is fatal, causing an inability to breathe, coma
and death [33, 34].
In the United States, acute intoxication results in 2,200 deaths per year directly, and
more than 30,000 deaths per year indirectly. In 2014, ethanol-related reckless driving
caused 9,967 deaths, amounting to 31% of overall driving fatalities in the United States.
1,825 college students died from ethanol-related unintentional injuries [35]. 696,000
students aged between 18 and 24 were assaulted by another student who had been drinking
[36]. 97,000 students aged between 18 and 24 reported ethanol-related sexual assault and
date rape [36].
AUD
AUD is characterized by ethanol abuse and ethanol dependence despite the
knowledge of negative consequences. The prefrontal cortex, temporal cortex, and
cerebellum are the most affected brain regions, manifested by volume loss of cortical and
subcortical structure and shrinkage of both white matter and gray matter [37, 38]. This
structural change is coupled with cognition deficits, visual and spatial recognition and
learning inability, and impaired movement coordination [37, 39]. It has been proposed that
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chronic ethanol abuse can cause an alteration of brain structure and thereby impair
behavioral control that in turn, can further promote ethanol abuse [37].
According to the 2015 NSDUH, 15.1 million adults aged 18 and older,
approximately 6.2% of this age group were diagnosed with AUD. They included 9.8
million men, about 8.4% of men in this age group and 5.3 million women, about 4.2% of
women in this age group. An estimate of 623,000 adolescents aged 12-17, about 2.5% of
this age group had AUD. They included 298,000 males, about 2.3% of males in this age
group and 325,000 females, about 2.7% of females in this age group. Roughly 20% of
college students aged between 18 and 22 met the criteria for AUD [40-42].
FASDs
FASDs refer to a spectrum of fetal disorders due to women drinking in pregnancy.
The phenotypes associated with FASDs include a small head, retarded growth, abnormal
appearance, and behavior problems. FAS is the most severe form of FASDs, which could
be attributed to the damage to CNS at the structural, neurological, and functional level. The
occurrence of FAS birth and FASDs is about 0.1% and 1% respectively; however, drinking
large quantities, e.g., 4-6 drinks in a short time, gives a risk of 50% to a FAS birth [43].
The prevalence of FAS in the United States was estimated by the Institute of
Medicine in 1996 to be between 0.5 and 3.0 cases per 1,000. More recent reports from
specific U.S. sites reported the prevalence of FAS to be 2 to 7 cases per 1,000, and the
prevalence of FASDs to be as high as 20 to 50 cases per 1,000 [44, 45].
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1.5
1.5.1

Ethanol Consumption and Neurodegeneration
Ethanol-induced Neurodegeneration
One of the most devastating features in FASDs and AUD is the damage to the

central nervous system that manifests as neuronal loss or degeneration [46-51]. This
structural damage is accompanied by neurological and functional impairments [37, 52].
Postmortem analysis and in vivo imaging of brain structure of alcoholics found significant
volume loss of cortical and subcortical structure and shrinkage of white matter and gray
matter [37, 38]. The frontal cortex, especially the prefrontal cortex, was the most affected
region, showing a significant neuronal loss [37, 53]. The frontal cortex regulates complex
cognitive function, e.g., thinking, judgment, planning, attention and memory formation in
conjunction with the hippocampus; the damage of the frontal cortex causes a range of
neurological and behavioral abnormalities [37, 39]. It has been suggested that the alteration
of brain structure due to ethanol consumption may reinforce the loss of behavioral control
on ethanol abuse that can further deteriorate ethanol abuse and brain damage [37, 54].
It is noteworthy that abstinence from ethanol may be associated with a recovery of
brain damage [37, 55]. It was reported that short-term abstention, e.g., one month was
linked with an increase of gray matter and long-term abstinence, e.g., one year was
associated with shrinkage of the third ventricle [55]. Magnetic resonance spectroscopy
showed that there was a significant improvement in neuronal integrity during abstinence
[55]. Likewise, cognitive deficits such as learning, spatial recognition, attention, and motor
function, improved with abstinence as well [56]. The potential of this recovery and the
extent of regeneration varied across brain regions and were dependent on factors such as
genetic variation, drinking pattern, and age [37].
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1.5.2

Mechanisms that Underlie Ethanol-induced Neurodegeneration
Ethanol intoxication has been suggested to inhibit N-methyl-D-aspartate (NMDA)

receptors and increase the density of voltage-gated calcium channels in the brain [57, 58].
Excessive excitability of glutamate receptor and calcium ion channel during ethanol
withdrawal was regarded as the mechanism for ethanol-induced neurodegeneration.
However, the employment of inhibitors or antagonists for glutamate receptor or calcium
ion channels was not able to block ethanol-induced brain damage [59, 60]. Moreover,
mounting evidence showed that alcoholic neurodegeneration occurred mainly during
intoxication rather than during ethanol removal [39, 61]. In agreement with this finding,
the occurrence and frequency of intoxication were linked with the extent of alcoholic brain
damage [37]. Currently, multiple mechanisms are appreciated with oxidative stress and
neuroinflammation

regarded

as

the

main

mechanisms

for

ethanol-induced

neurodegeneration [37, 62-64].
Ethanol can cross the blood-brain barrier (BBB) and activate nuclear factor kappalight-chain-enhancer of activated B cells (NF-κβ) mediated inflammatory response [65].
As a consequence, inflammatory cytokines or substances such as high mobility group box
1 (HMGB1) and damage-associated molecular patterns (DAMPs) are released from
microglial cells to activate toll-like receptors (TLRs) and receptor for advanced glycation
end products (RAGE) that in turn, further promote NF-κβ mediated inflammatory response
[65]. On the other hand, ethanol can induce inflammation in the liver and cause a systemic
inflammation; the induced inflammatory cytokines, e.g., tumor necrosis factor-alpha
(TNFα), can cross BBB through receptor-mediated transportation and contribute to the
existing inflammation in the brain [65, 66]. Collectively, the induced inflammation arising
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from local inflammation and reinforcement from systemic inflammation constitutes one of
the mechanisms for ethanol-induced neurodegeneration, manifested by neuronal death,
axonal degeneration and synaptic dysfunction [65] (Figure 1.1).
The second mechanism for ethanol-induced neurodegeneration is oxidative stress
[64, 67, 68]. Several mechanisms are accountable for the genesis of oxidative stress. First,
ethanol metabolism in cells is coupled with the conversion of nicotinamide adenine
dinucleotide (NAD+) to NADH [69]. The backward reaction from NADH to NAD+
increases the formation of reactive oxygen species (ROS) [69]. Meanwhile, ethanol
metabolism in microsomes catalyzed by cytochrome P450 2E1 (CYP2E1) can increase
ROS formation directly [69]. Alternatively, ethanol mediates the activation of NADPH
oxidase (NOX), thereby increasing ROS formation [69, 70]. Oxidative stress in cells is
devastating. On the one hand, oxidative stress causes neuronal death directly; on the other
hand, it can crosstalk with the inflammatory pathway and potentiate the harmful effects of
neuroinflammation [71, 72]. Besides, it has been reported that oxidative stress can inhibit
neurogenesis and therefore can indirectly contribute to a neuronal loss [65] (Figure 1.1).
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Figure 1.1. Mechanisms that Underlie Ethanol-induced Brain Damage.
Fulton T Crews, et al., 2016. See text for detail.

1.5.3

ER Stress and Neurodegenerative Diseases
In eukaryotic cells, ER regulates protein folding and primes the degradation of

misfolded proteins through proteasome, lysosome, and autophagy pathways [73]. Protein
folding in the ER is tightly regulated, and only properly folded proteins can pass through
quality control surveillance and shuttle to the Golgi compartment. Misfolded proteins are
retained in ER through interactions with chaperones and eventually targeted for
degradation either by the ubiquitin-proteasome system (UPS) or by the autophagylysosome system. A variety of conditions, such as pathogen infection, nutrient deprivation,
inflammation, alterations in ER luminal Ca2+ or redox status, and toxic chemicals can
disrupt protein folding in the ER and cause the accumulation of unfolded proteins, which
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is referred to as ER stress [74]. ER stress activates an unfolded protein response (UPR) to
eliminate unfolded or misfolded proteins in the ER. The UPR is regulated through three
ER-localized transmembrane proteins, Inositol-requiring kinase (IRE1), protein kinase
RNA-like endoplasmic reticulum kinase (PERK), and activating transcription factor 6
(ATF6) [75]. When ER stress is excessively activated, and the cellular function cannot be
restored, it leads to cell death [76].
Accumulation of misfolded protein is a sharing characteristic of many
neurodegenerative diseases such as Parkinson's disease, Alzheimer’s disease, Huntington’s
disease, and Amyotrophic Lateral Sclerosis (ALS) [76, 77]. ER stress has been implicated
as one of the underlying mechanisms for these neurodegenerative diseases. With animal
and preclinical models, targeting UPR through pharmacological and genetic approaches in
these diseases generated profound effects on the outcomes of these diseases [76]. For
example, Perk haploinsufficiency exacerbated ALS in transgenic mice induced with a
SOD1 mutation [78]; Employment of salubrinal, an eIF2α phosphatase inhibitor, blocked
protein translation and ameliorated ER stress, thereby generating positive effects in
improving neuronal survival and motor performance [76, 79, 80]. It is noteworthy that
inhibition of ER stress is not certainly associated with the improvement of the diseases.
Dependent on the disease models and the stages of the disease, ER stress inhibition that
has proved to be effective in one disease model may be ineffective or operate oppositely in
the other disease models. For instance, salubrinal improved the outcome of ALS and
Parkinson disease by reducing ER stress but exacerbated Prion-related disease in Scrapie
prion-infected mice [81]. Ethanol-induced ER stress is linked with multiple organ injuries.
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ER stress was found in acute pancreatitis [82-84] and implicated in Ethanol-induced liver
disease (ALD) and in the myocardium of Ethanol-fed mice [85-90].
1.5.4

MANF and its Implication in ER Stress
MANF, also recognized as arginine-rich mutated in early stages of tumor

(ARMET) was identified in a ventral mesencephalic astrocyte cell line 1 in search of
astrocyte-derived neurotrophic factor [91]. MANF is widely expressed in the cerebral
cortex, hippocampus, and cerebellum and can also be detected in the liver, kidney, and
testes [92]. The crystal structure of mammalian MANF has revealed that MANF contains
several motifs: a saposin-like domain in the amino-terminal, an SAP-like domain in the
carboxy-terminal and a C-X-X-C motif. The saposin-like domain can interact with lipid
and membrane, thereby linking MANF to the ER membrane. The SAP-like domain shares
high homology with the SAP domain in Ku70 that has been reported to interact with
proapoptotic proteins such as Bad and Bax and inhibit their function. The C-X-X-C motif
is commonly found in protein disulfide isomerase and mediates the formation of disulfide
bonds [93, 94].
MANF is involved in neural development, such as neurite outgrowth and neuronal
migration [95]. MANF has been found to have trophic effects on embryonic dopaminergic
neurons both in vitro and in vivo [91, 96, 97]. Neves et al. showed MANF was induced in
innate immune cells during retina injury; the induced MANF was involved in the
alternative activation of microglial cells, which was essential for retinal repair and
regeneration [98]. It has also been shown that MANF can cause insulin resistance in the
neurons of the hypothalamus, thereby increasing food intake and causing hyperphagia
phenotype in mice [99]. Meantime, MANF has been found to respond to ER stress and was

17

identified as a protein up-regulated by UPR [100]. It was upregulated in myocardial
infarction and brain diseases such as cerebral epilepsy and ischemia wherein ER stress was
a sharing characteristic [92, 101] (Figure 1.2).

Figure 1.2. Background on MANF. See text for detail.

1.6

Ethanol Consumption and Neurogenesis Dysregulation
Neurogenesis is the process in which neural stem cells (NSCs) give rise to various

types of neurons of the organism [102, 103]. In humans and rodents, neurogenesis is most
active during the embryonic stage [104]. Whether neurogenesis occurs in the adult brain is
debatable for decades. The first discovery of neurogenesis in the adult rodent brain was
18

made in the hippocampal dentate gyrus in the 1960s [105]. Subsequent studies confirmed
this finding and well established the existence of neurogenesis throughout life at least in
two brain regions: (1) in the subgranular zone (SGZ) of the hippocampal dentate gyrus, a
brain region critical for learning and memory formation, and (2) in the subventricular zone
(SVZ) of the anterior lateral ventricles, the origin of olfactory bulb neurons [104, 106, 107].
Neurons born in the adult SVZ can migrate through the rostral migratory system (RMS)
and eventually evolve into granule neurons and periglomerular neurons in the olfactory
bulb [102]. Neurons born in the adult SGZ can migrate to the granule layer of the dentate
gyrus and differentiate into granule cells [102]. These newly formed neurons need to
integrate into local circuitry and receive input from other neurons to become functional.
Neurogenesis in adulthood is the most robust form of neuroplasticity in the adult mouse
brain, which is associated with various brain functions such as mood, learning, cognition,
and memory formation [102, 103].
Neurogenesis is heavily regulated by genetic and environmental factors at multiple
levels, including NSCs proliferation, differentiation, migration, and the survival and
maturation of newly born neurons [102, 103]. Ethanol exposure may affect this process at
any one of these individual phases or through a combination of the effects at multiple stages
[108]. Depending on the species and Ethanol exposure paradigm, Ethanol may promote or
inhibit neurogenesis [108]. For example, it was shown that a single dose of 5 g/kg of
ethanol reduced NSCs proliferation by 40% in rats [109]. The neurogenesis inhibitory
effects of ethanol were confirmed with another ethanol exposure paradigm; rats fed with
an ethanol-containing liquid diet that rendered a lower BEC (86.4 mg/dl) also exhibited a
40% decrease in neuronal proliferation [110]. However, the repetition of similar ethanol
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exposure on mice presented an opposite finding; mice fed with an ethanol-containing diet
for 14 days showed a 2-fold increase in the number of proliferating neurons in the SGZ of
the dentate gyrus [111, 112]. These conflict findings may result from a difference in term
of ethanol metabolism rate and consequently, a timing shift of ethanol-induced
neurogenesis in mice when compared to rats [108]. Besides, a few studies showed no effect
or an increase of neurogenesis upon chronic ethanol exposure in rats and argued the
decrease of neurogenesis was an acute effect or a transient effect resulting from ethanol
exposure [108, 113]. These controversial findings may result from a range of variances
such as ethanol exposure patterns that leads to different BECs at the time of analysis and
the method or markers that are used to label proliferative cells [108]. Overall, the vast
majority of in vivo findings supported that ethanol-induced intoxication can cause a
reduction in neurogenesis due to the inhibitory effects of ethanol on cell proliferation.
1.7

Study Overview and Objectives
Drinking too much on a single occasion or overtime is harmful, resulting in a range

of health problems. It may affect the proper function of the brain, heart, liver, and pancreas
and trigger tumorigenesis or promote the progression of existing tumors. Neuronal loss or
degeneration is one of the most devastating features in FASDs and AUD [46-49].
Postmortem and in vivo imaging of alcoholic brains revealed a significant alternation of
brain structure and neuronal loss [37]. The brain structure alternation and neuronal loss
were coupled with neurological dysfunction, manifested by the impairment of visualspatial learning, memory formation, motor performance, and cognitive deficits [37, 52].
Currently, multiple mechanisms are believed to be responsible for ethanol-induced
neurodegeneration [37, 62-64]. Misfolded proteins are accumulated in many
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neurodegenerative diseases, and ER stress is believed to be an underlying mechanism for
their pathogenesis [76]. We previously showed that ethanol induces ER stress in cultured
neuronal cells and the developing brain [114, 115]. However, whether ER stress is involved
in ethanol-induced neurodegeneration is unclear. In my first project, the role of ER stress
in ethanol-induced neurodegeneration was investigated with a binge drinking animal
model and cell culture.
MANF was identified as a neurotrophic factor in an astrocyte cell line and has been
proven to be neuroprotective, especially to dopaminergic neurons both in vivo and in vitro
[91, 96, 97]. Several lines of studies found MANF was an ER stress-responsive protein and
up-regulated in many pathophysiological conditions wherein ER stress was an underlying
characteristic [92, 101]. We recently showed that ethanol exposure increased MANF level
in the developing brain [115, 116]. Therefore, we postulated that the induced MANF may
be associated with ER stress regulation. Hence, in my second project, the role of MANF in
ER stress regulation and its association with ethanol-induced neurodegeneration were
examined.
Currently, scientists believe that, under normal conditions, adult neurogenesis
exists at least in two brain regions: the SVZ of the lateral ventricles and the SGZ of the
dentate gyrus in the hippocampus [102, 103]. Adult neurogenesis is regulated at a multitude
of levels, including the proliferation of NSCs, fate determined differentiation of progenitor
cells, and the survival and maturation of newly born neurons [102, 103]. Various signaling
pathways, growth factors, cytokines, neurotransmitters, and neurotrophic factors are
involved in this complex regulation of neurogenesis. Because MANF is a neurotrophic
factor, we speculated that MANF may participate in or affect the process of adult
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neurogenesis. In my third project, the effects of MANF deficiency on neurogenesis in the
SVZ of the anterior lateral ventricles and SGZ of the hippocampal dentate gyrus in the
mouse brain were investigated.
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CHAPTER 2. MATERIALS AND METHODS
2.1

Regents and Antibodies
Reagents were purchased for blood ethanol levels from Analox Instruments

(London, UK). 4-Hydroxynonenal (HNE) adduct assay was from Cell Biolabs, Inc. (San
Diego, CA). Rapamycin was from EMD Millipore (Burlington, MA). ATF6 was from Life
Span Biosciences (Seattle, WA). Mammalian target of rapamycin (mTOR), p-mTOR,
4EBP1, p-4EBP1, p70S6K, p-p70S6K, eukaryotic initiation factor 2α (eIF2α), p-eIF2α,
Ki-67, p-PERK, cyclinE1, cyclin A2, Sox2, NeuroD1, HA, phospho-histone H3 (pHH3),
Calbindin, PCNA, p15, p27, cleaved caspase-3, and cleaved caspase-12 antibodies, were
from Cell Signaling Technology (Danvers, MA). GRP78 antibody was from Novus
Biologicals (Littleton, CO). X-box binding protein-1s (XBP1s) antibody was from
BioLegend (San Diego, CA). Doublecortin (DCX), BrdU and MANF antibodies were from
Abcam (Cambridge, MA). CCAAT/enhancer-binding protein homologous protein
(CHOP) antibody was from Thermo Fisher Scientific (Rockford, IL). HRP-conjugated
anti-rabbit and anti-mouse secondary antibodies were from GE Healthcare Life Sciences
(Piscataway, NJ). Mounting media containing 4′, 6-diamidino-2-phenylindole (DAPI) was
from Vector Laboratories (Burlingame, CA). Alexa-488 conjugated anti-rabbit and Alexa594 conjugated anti-mouse antibodies were from Life Technologies (Grand Island, NY).
Ketamine/xylazine was from Butler Schein Animal Health (Dublin, OH). Other chemicals
and reagents were purchased either from Sigma-Aldrich or Life Technologies (Frederick,
MD).
2.2

Immunoblotting
Proteins were extracted from the cerebellum, cortex, subcortical area, heart, liver,
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or cultured cells. Around 30–50μg of extracted protein was used in immunoblots to
examine the levels of ER stress markers (GRP78, p-eIF2α, CHOP, XBP1s, and ATF6),
mTOR signaling (p-mTOR, p-4EBP1, and p-p70S6K), MANF, HA, cell cycle inhibitors
(p15 and p27), cell cycle markers (PCNA, pHH3, cyclin A2 and cyclin E1), neural
progenitor markers (Sox2 and NeuroD1) and apoptotic markers (cleaved caspase-3 and
caspase-12). The nitrocellulose membranes were first probed with specific primary
antibodies overnight at 4°C. After washing with phosphate-buffered saline (PBS)
containing 0.05% Tween-20 three times, the membranes were incubated with anti-rabbit
or anti-mouse secondary antibodies (horseradish peroxidase-conjugated) for 1h at room
temperature.

Protein-specific

signals

were

then

detected

with

enhanced

chemiluminescence substrate (GE Healthcare, Chalfont, Buckinghamshire, UK) using a
Chemi™Doc imaging system (Bio-Rad 215 Laboratories, Hercules, CA) and then
quantified with the software of Image lab 5.2 (Bio-Rad Laboratories, Hercules, CA).
2.3

Fluoro-Jade C Staining
Fluoro-Jade C is fluorescein-derived fluorochrome. Fluoro-Jade C staining is a

commonly used method to label degenerating neurons due to its great signal-to-background
ratio [117]. Brain tissues were fixed with 4% paraformaldehyde (PFA) overnight and then
transferred to 30% sucrose to dehydrate. The brain tissues were sectioned sagittally at a
thickness of 15 μm and then mounted onto superfrost/plus slides. After immunostained
with NeuN (a marker for mature neurons) antibody, these sections were rehydrated in
distilled water for 2 minutes and then transferred to a 0.06% potassium permanganate
solution and incubated for 10 minutes. After rinsing in distilled water for 2 minutes, the
sections were covered with Fluoro-Jade C working solution (0.0001% Fluoro-Jade C in
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0.1% acetic acid) for 10 minutes. Next, the sections were rinsed in distilled water,
dehydrated and covered with mounting and imaged with an inverted fluorescent
microscope (IX81, Olympus).
2.4

In vivo Labeling with BrdU
BrdU (Bromodeoxyuridine/5-Bromo-2'-deoxyuridine) is an analog of the

nucleoside thymidine and can be incorporated into DNA during replication in vivo and in
vitro [118, 119]. In our study, BrdU was constituted in PBS to make a sterile solution of
10 mg/ml. Based on the literature, BrdU solution was administered to postnatal day 6 (PD6)
pups (CTL and KO) through intraperitoneal injection at a dose of 100 mg/kg [120]. At 4
hours after BrdU treatment, the animals were sacrificed and the brains were removed,
dissected, fixed, paraffin-embedded, sectioned, and then subjected to analysis with
antibodies against BrdU and Calbindin according to standard immunofluorescence
protocol (IF).
2.5

Immunohistochemistry and Immunofluorescence
Mouse brains were dissected and processed for immunofluorescence (IF) or

immunohistochemistry (IHC) staining as previously described [115, 121]. In brief, brain
tissues were fixed with 4% paraformaldehyde (PFA) overnight and then transferred to 30%
sucrose to dehydrate. Next, the brain tissues were sectioned sagittally at a thickness of 15
μm and then mounted onto superfrost/plus slides. The slides mounted with brain sections
were incubated with 0.3% H2O2 in methanol, permeabilized with 1% Triton X-100 and
blocked with 1% BSA at room temperature. After that, these slides were immunostained
with the following individual or combined primary antibodies: DCX (1:500), Ki-67
(1:500), MANF (1:200), cleaved caspase 3 (1:200), CHOP (1:50), or NeuN (1:200). The
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slides were then incubated with anti-rabbit or anti-mouse secondary antibody conjugated
to Alexa Fluor 488 or biotin. The immunolabelings were visualized using nickel-enhanced
3,3’-Diaminobenzidine (DAB) or Alexa Fluor 488 (green) and imaged with an inverted
fluorescent microscope (IX81, Olympus).
2.6

Protein Carbonyl Assay and HNE Assay
Protein carbonyl assay is a colorimetric assay for the measurement of oxidized

proteins, indicative of oxidative stress. Cerebellum, cortex or liver were homogenized in 1
ml of cold buffer containing 50 mM of phosphate, pH 6.7 and 1 mM EDTA with the final
protein concentration at a range of 1-10 ug/ul. The homogenate was centrifuged, and the
supernatant was collected for the assay. Briefly, 200 ul of the supernatant was transferred
to two 2 ml tubes; one tube was the sample tube, and the other one was the control tube.
800 µl of 2,4-dinitrophenylhydrazine (DNPH) was added to the sample tube, and 800 ul of
2.5 M HCl was added to the control tube. Both tubes were vortexed every 15 minutes and
remained at room temperature for one hour. Next, 1 ml of 20% trichloroacetic acid (TCA)
was added to the sample tube and the control tube, and the mixtures remained on the ice
for five minutes. Proteins were precipitated by centrifuging, and the pellets were washed
using ethanol/ethyl acetate mixture twice. The protein pellets were resuspended in 500 ul
of guanidine hydrochloride. Then, 150 ul of protein was transferred from the sample tube
and control tube to three wells in a 96-well plate, and the absorbance was measured at a
wavelength of 360-385 nm using a plate reader. The corrected absorbance (CA) was
calculated by subtracting the average absorbance of the control tube from the average
absorbance of the sample tube. The final carbonyl content was determined using the
following equation: Carbonyl content (mmol/mg)=[CA/(*11 mM -1)]*(500 µl/ 200 µl)
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/(protein mg/ml).
HNE adduct assay is for the measurement of lipid peroxidation, another index for
oxidative stress. Protein lysates were prepared from samples (cerebellum, cortex, or liver).
50 µl of protein lysates or HNE-BSA standards were added to wells pre-coated with HNE
conjugates. After a brief incubation, 50 µl of the diluted HNE antibody was added to the
wells and incubated for 1 hour, followed by the addition of an HRP conjugated secondary
antibody. The wells were washed and then incubated with substrates for 20 minutes. The
absorbance was read on a microplate reader using 450nm, and the content of HNE protein
adducts was calculated by comparison with a predetermined HNE-BSA standard curve.
2.7

Cell Culture and Drug Treatments
N2a cells are mouse neuroblastoma cell line and were maintained in DMEM

medium

supplemented

with

10%

fetal

bovine

serum

(FBS)

and

1%

streptomycin/penicillin. In ethanol treatment, N2a cells were serum-starved overnight and
then incubated with complete medium containing 0.2%, 0.4% (volume/volume) ethanol
for 12 hours. Tunicamycin (TM) is a conventional ER stress inducer by inhibiting N-linked
glycosylation. We dissolved TM in dimethyl sulfoxide (DMSO) to a concentration of 10
mg/ml. In TM treatment, N2a cells were serum-starved overnight and then treated with TM
at a working concentration of 0.5 or 1 µg/ml in complete medium for 12 hours. 4-PBA is
a chemical chaperone that is widely used to block ER stress induction. We dissolved 4PBA in water at a concentration of 20 mg/ml. To block ER stress induction, N2a cells were
serum-starved overnight and then pretreated with 4-PBA at a working concentration of 10
mM in complete medium for two hours prior to ethanol or TM treatment. Rapamycin is an
mTOR inhibitor and was dissolved in DMSO at a concentration of 1 mM. In rapamycin
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treatment, N2a cells were serum-starved overnight and then treated with rapamycin at a
working concentration of 0.5, 1, 2, 5 or 10 µM in complete medium for 12 hours. An equal
volume of DMSO or water was used as the corresponding control in these drug treatments
of N2a cells.
2.8

RNA Isolation and Real-time RT-PCR
Total RNA from the brain or liver was extracted using Trizol Reagent (Life

Technologies) and treated with RNA-free DNAase I to remove remnant DNA as described
previously [122]. cDNA used for gene detection was synthesized as described previously
using SuperScript III reverse transcriptase and random primers [122]. The primers used for
this study were purchased from Fisher Scientific as below: UBXN6, Mm01272178;
HSPA5, Mm00517691; UBE2J2, Mm01263784; PDIA6, Mm01270904; ERLEC1,
Mm00458735; HYOU1, Mm00491279; Manf, Mm00512511; Tnf-α, Mm099999068;
IL1β, Mm00434228; IL-6, Mm00446190; MCP-1,

Mm00441242; 18s

rRNA,

Mm03928990. The relative expression was normalized to internal control (18s rRNA)
using cycle time (Ct). The relative difference between the control and treatment group was
expressed and calculated as relative increases using 2-ΔΔCt and setting control as 1.
2.9

MANF Adenovirus and Transduction
MANF adenoviruses (AD-MANF) were prepared in Applied Biological Materials

(ABM). In brief, a DNA sequence encoding MANF was inserted into pAdenoG-HA vector
and then packaged into adenoviruses (Cat No. 210179A). An empty vector virus, ADvector (Cat. No. 000047A) was used as the control virus. Both adenoviruses were prepared
at titer more than 1x106pfu/ml and amplified in our lab by transducing HEK293 cells. To
obtain the overexpression of MANF in N2A cells, we infected N2A cells with AD-MANF
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or AD-vector for 48 hours following the protocol from manufacture (ABM). In brief, N2A
cells were seeded in 6-well plates or 6-well chambers at 50% confluency one day before
transduction. In transduction, N2A cells were covered with viral culture (AD-MANF or
AD-vector) for 2 hours and then incubated with fresh media. After transduction for 48
hours, N2A cells were collected for the subsequent immunochemical or flow cytometric
analysis.
2.10 Generation of Manf Knockout Cell Lines
Several stable Manf-knockout cell lines were established in our lab using the
CRISPR/Cas9 gene-editing method. In brief, N2A cells were transfected with Manf
CRISPR/Cas9 KO plasmid (Cat No. sc-428989-NIC) or the control plasmid (Cat No. sc418922) according to the protocol from manufacture (Santa Cruz Biotechnology). Colonies
with successful transfection of the KO plasmids or control plasmids were visually
confirmed by the detection of the green fluorescent protein (GFP) and immunoblot of
MANF. Three colonies with complete Manf knockout (verified by immunoblot of MANF)
were selected for the following immunochemical or flow cytometric analysis with colonies
transfected with control plasmids as the control.
2.11 Cell Cycle Analysis
To determine the effects of MANF on cell cycle progression, N2A cells with
MANF overexpression (AD-MANF) or Manf knockout (KO) and their corresponding
control cell lines were stained with propidium iodide (PI) and then subjected to cell cycle
analysis by flow cytometry. In brief, samples were trypsinized and fixed in cold 70%
ethanol for 30 minutes. Next, these samples were treated with ribonuclease I (5ug/ml),
incubated with PI for at least 30 minutes and then sent to Flow Cytometry and Immune

29

Monitoring Core for flow cytometric analysis of PI content. ModFit LT V3.3.11 (software)
was used to quantitate the percentage of cells in each cell cycle phase.
2.12 TUNEL Assay
Brain samples (sections) were prepared and mounted to slides as described in the
section of “Immunohistochemistry and Immunofluorescence” and then subjected to
TUNEL analysis according to the protocol from manufacture (Roche, Cat No.
11684817910). In brief, the brain sections/slides were incubated with a blocking solution
(3% H2O2 in methanol) for 10 minutes and then incubated with permeabilization solution
(0.1% Triton X-100 and 0.1% sodium citrate) for 2 minutes. Next, these sections/slides
were incubated with TUNEL reaction mixture at 37 °C in a humidified atmosphere in the
dark for 60 minutes. A brain section incubated with labeling solution was used as the
negative control and a brain section digested with DNase I and incubated with TUNEL
reaction mixture as the positive control. The slides were then mounted with DAPIcontaining medium and imaged with an inverted fluorescent microscope (IX81, Olympus).
2.13 Cell Viability and Proliferation Assay
Cell viability and proliferation assay were performed using MTT assay according
to the protocol from manufacture (Roche, Cat No. 11465007001). In brief, N2A cells in
96-well plates were transduced with adenoviruses (AD-CTL or AD-MANF) as described
above for 72 hours. 10 ul of MTT labeling reagent was then added into each well and
incubated for 4 hours in a humidified atmosphere. Next, 100 ul of the solubilized solution
was added to each well and incubated overnight in the incubator. The relative cell numbers
were assessed by measuring the spectrophotometric absorbance of the samples using a
microplate reader at the wavelength of 595 nm.
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2.14 Animal Models and Behavioral Tests
2.14.1 Animal Models
Binge Ethanol Drinking Mice
All study procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Kentucky and performed following regulations
for the Care and Use of Laboratory Animals set forth by the National Institutes of Health
(NIH) Guide. Eight-week male C57BL/6 mice were purchased from Jackson Laboratories
(Bar Harbor, Maine). Twenty four male mice were used for each time course and randomly
assigned to two groups: water control group (n=12) and the ethanol group (n=12). The mice
received water or ethanol (5 g/kg, i.g., 25% ethanol w/v) intragastrically once daily for 1,
5 or 10 days with volume matched. One hour after the last gavage, blood was extracted
from the mouse tail vein, spun down, and the supernatant (serum) was aspirated for the
measurement of blood ethanol concentration using an Analox AM 1 analyzer (Lunenburg,
MA). Six hours after the last gavage, the mice were sacrificed and the brains were dissected
for biochemical or histological analyses. For behavioral tests, twenty male mice were
gavaged with water (n=10) or ethanol (n=10) at the same dose for 10 consecutive days and
then subjected to behavioral tests as described below.

Nervous System (NS)-Specific Manf Knockout
Embryonic stem cell clone EPD0162_3_D06 (Manf

tm1a(KOMP)Wtsi)

as illustrated in Figure

2.1 was generated by the Wellcome Sanger Institute and injected into blastocyst by the
Knockout Mouse Project (KOMP) Repository and the Mouse Biology Program at the
University of California (UC) Davis. The generated chimeric mice were then bred with
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C57BL/6N mates. Then via UC Davis Mouse Biology Program, MANF mice were crossed
with an FLP recombinase line for in vivo recombination to convert to the conditional
(floxed) allele. The FLP recombinase line was obtained from the MMRRC: C57BL/6Tg(CAG-Flpo)1Afst/Mmucd, 032247-UCD. Two generations of breeding were performed
to ensure excision in the germ cells and remove the FLP transgene. They also bred to
homozygosity at our request. Nestin-Cre+/ transgenic mice (B6.Cg-Tg(Nes-Cre)1Kln/J)
were obtained from Jackson Laboratory. Manf floxed+/+ mice were first crossed with
Nestin-Cre+/ mice to generate Manf floxed+/- Nestin-Cre+/ mice. Then the offspring was
crossed with Manf floxed+/+ mice to generate Manf floxed-/- Nestin-Cre+/ mice in which
Manf was specifically knocked out in the central nervous system and peripheral nervous
system. For genotyping, mice tail DNA was extracted using Fast Tissue/Tail PCR
Genotyping Kit (EZ BioResearch) according to the manufacturer's instructions. Primers
used for genotyping are as follows: Manf-f2, GAGATGGCGCAACGCAATTAATG;
Manf-r2,

CCATGGTGATGCTGTAACTGTCACG;

Manf-r1,

TGCTCAGCTGCAGAGTTAGAGTTCC;

Manf-f1,

TGAAGCAAGAGGCAAAGAGAATCGG. Cre-F, GGTTCGCAAGAACCTGATGG;
Cre-R, GCCTTCTCTACACCTGCGG. Touch-Down PCR protocol was used for the
reactions. For the first 10 cycles which annealed at 65°C decreasing in temperature by 1°C
per cycle and an additional 30 cycles annealed at 55 °C. The amplifications were
performed in 12 µl volume, and the PCR cycles were 94°C for 5 min, 94°C for 15 sec,
annealing for 30 sec, 72°C for 40 sec and final extension 72°C for 5 min. The length of
amplified bands for Manf+/+, Manf

flox/flox

(CTL), and conditional Manf

locus are listed as below (Figure 2.1).
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-/-

(cKO) targeted

Figure 2. Schematic Illustration of NS-Specific Manf Knockout. Schematic
representation of Manf+/+ wild-type, Manfflox/flox, and Cre::Manf-/- targeted locus. E:
exon. Arrowheads indicate priming sites used in genotyping by PCR. See text for
detail.
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Ethanol- and TM-induced Neurodegenerative Mice
Two animal models were used in this study to investigate the effects of MANF on
ER stress-induced neuronal damage: ethanol-induced neurodegeneration and TM-induced
neurodegeneration. In ethanol-induced neurodegeneration, PD7 pups (CTL and cKO) were
injected with PBS or ethanol (1.5 g/kg, 20% solution in PBS) subcutaneously twice at a
two-hour interval. Neuronal apoptosis and ER stress were assessed 8 hours after the first
injection. In TM-induced neurodegeneration, PD7 pups (CTL and cKO) were injected with
150 mM dextrose (Mock treatment) or TM (3 mg/kg, 30% solution in dextrose)
subcutaneously once. Neuronal apoptosis and ER stress were assessed 24 hours after the
injection. For pre-inhibition of ER stress with 4-PBA, PD6 pups (CTL and cKO) were
injected with 4-PBA or PBS subcutaneously twice at a dose of 100 mg/kg 24 hours and 2
hours in advance and then subjected to ethanol or TM treatment following the same
procedure as above. Neuronal apoptosis and ER stress in the brain from the CTL group and
cKO mice were evaluated with immunoblotting and immunochemistry of ER stress
markers and apoptotic markers as well as TUNEL assay.

2.14.2 Behavioral Tests
Open Field Activity and Elevated Plus Maze are experimental tests used to assess
general levels of locomotor activity and anxiety in rodents. Morris Water Maze is a
behavioral procedure to assess spatial learning and memory in rodents. They have been
widely used to study the effect of ethanol exposure on animal behavioral changes [123,
124]. Behavioral tests were started on the third day after the last gavage when the animals
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were recovered from intoxication at the University of Kentucky Rodent Behavior Core.
Open Field Activity (OFA)
All animals were brought from their housing room to the test room in clean holding
cages for a ten-minute habituation period before testing. The open-field test was conducted
in a square chamber (50 x 50 x 40 cm) with opaque white walls and floors. Animals were
placed in the chamber and tested for 15 minutes individually using a computer-operated
EthoVision XT system (Noldus, Wageningen, The Netherlands). The total distance
traveled and time spent in the center area was calculated by tracking the animal’s midpoint
relative to predetermined boundaries on the video images of each apparatus. The center
was defined as a centered, square zone with a length and width half the length and width
of the open field.
Elevated Plus Maze (OPM)
Following the OFA, the test animals were given a two-hour rest period before
beginning the EPM test. EPM is made up of two open arms (50 x 10 cm) and two closed
arms (50 x 10 x 40 cm) above the floor. Each animal was placed in the intersection between
open arms and closed arms and tested for a five-minute session using a computer-linked
EthoVision XT system. The total distance traveled, and total entries to the open arms or
closed arms were recorded and calculated by tracking the animal’s midpoint relative to
predetermined boundaries on the video images of each apparatus.
Morris Water Maze (MWM)
All animals were rested for one day and then transferred to the test room for a tenminute habituation period before MWM testing. The MWM is a round plastic tub, about
107 cm in diameter, made opaque using white non-toxic water-based paint and then filled
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with water (25-26°C). We placed a hidden escape platform (15 x 15 cm) 1 cm under the
surface of the water in a fixed location. Four visible extra-maze cues were posted on the
walls around the maze. Each mouse was placed in the pool from different drop locations
between trials and allowed to swim until they found the submerged platform. If the animals
could not find the platform within 60 seconds, they were gently guided to the platform and
remained on the platform for 10 seconds before being removed for a five-minute intertrial
interval. Each animal had four trials for five consecutive days, and the latency to reach the
platform and distance traveled for each trial was recorded with EthoVision XT.
2.15 RNA Sequencing and Data Analysis
Total RNA was isolated from brain tissues of two groups of PD7 mice with each
group having three samples: CTL group and cKO group. Therefore, six RNA samples were
submitted to the University of Kentucky Genomics Core Laboratory for the whole
transcriptome sequencing. Libraries were assembled using the KAPA RNA HyperPrep
Kits with RiboErase (HMR) for Illumina Platforms and indexed with KAPA SingleIndexed Adapter Kit (KAPA Biosystems). Indexed libraries were pooled in equimolar
concentrations and the denatured pool diluted to a final concentration of 10 pM. This pool
was spiked with 5% PhiX Control library. The combined pool was clustered on board using
a HiSeq SR Rapid Cluster Kit v2 (Illumina) and sequenced on an Illumina HiSeq 2500
Sequencing system using a HiSeq Rapid SBS Kit v2 (Illumina).
The transcriptome of each sample was analyzed with ensemble GRCm38 Mouse
Transcriptome as reference. Transcript abundance was calculated with RNA-Seq by
Expectation-Maximization (RSEM) analysis [125] and differentially expressed (DE) genes
were calculated using EBSeq [126]. A false detection rate (FDR) analysis with a 0.05
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threshold was performed. The lists of DE genes were submitted to Enrichr for gene
ontology enrichment (GOEA) analysis [127].
2.16 Measurement of Blood-Ethanol Concentration (BEC)
One hour after ethanol gavage or ethanol injection, blood samples were collected
from the tail vein. The blood was centrifuged, and 10 ul of the plasma was used to measure
BEC using an Analox AM 1 analyzer (Lunenburg, MA) as previously described [128].
2.17 Statistics
The data was expressed as mean ± SEM, and statistical significance was determined
using Student Unpaired t-test, one-way ANOVA, or two-way ANOVA followed by
Bonferroni Multiple Comparison test (GraphPad Prism version 7). A p-value of less than
0.5 was considered statistically significant.
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CHAPTER 3. ER STRESS CONTRIBUTES TO ETHANOL-INDUCED
NEURODEGENERATION
3.1

Overview
Heavy alcohol use causes brain damage that manifests as neuronal loss and

dysfunction as well as mental and behavioral abnormalities. The aggregation of misfolded
proteins is a sharing trait among several neurodegenerative diseases, and ER stress has
been proposed as the underlying mechanism for their pathogenesis. We previously showed
that ethanol exposure induces ER stress in cultured neuronal cells and the developing
mouse brain [114, 115]. However, whether ER stress contributes to ethanol-induced
neurodegeneration is unclear. In this section, I investigated the role of ER stress in ethanolinduced neurodegeneration with a binging drinking animal model and cell culture.
3.2

Binge Ethanol Exposure Induces Neurodegeneration and Neuroinflammation
in the Adult Male Mouse Brain
BEC was measured on days 1, 5, and 10 on these male mice gavaged with water or

ethanol. The BEC is 351 ± 29 mg/dl on day 1, 374 ± 21 mg/dl on day 5, and 463 ± 25 mg/dl
on day 10 in the ethanol-treated group as compared to 1.7 ± 0.5 mg/dl on day 1, 6.4 ± 0.6
mg/dl on day 5, and 7.6 ± 0.5 mg/dl on day 10 in the water-treated group. We also measured
the body weights of these mice and found there was no significant difference in body
weight between the water-gavaged group and the ethanol-gavaged group (data not shown).
Next, we determined the effects of binge ethanol exposure on neurodegeneration. As
shown in Figure 3.1A-F, binge ethanol exposure for one day failed to induce the expression
of cleaved caspase-3 and caspase-12. However, binge ethanol exposure for 5 or 10 days
significantly increased the levels of cleaved caspase-3 and caspase-12 in the cerebellum
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and cerebral cortex. Cleaved caspase-3 is indicative of apoptosis, and cleaved caspase-12
suggests that the induced apoptosis originates from ER perturbation [129]. We confirmed
this ethanol-induced neurodegeneration with Fluoro-Jade C labeling, a method commonly
used to label degenerative neurons. As shown in Figure 3.1G, ethanol exposure for 10 days
increased the number of Fluoro-Jade C-positive cells in the cerebellum and cortex of
ethanol-exposed mice. The Fluoro-Jade C-labeled cells colocalized with NeuN, a marker
of mature neurons, which indicated the occurrence of neurodegeneration. Consistent with
the findings in the brain, ethanol also induced apoptosis in the liver, the primary organ for
ethanol metabolism (Figure 3.3A-B). Ethanol also increased the expression of some
proinflammatory cytokines and chemokines; binge ethanol exposure up-regulated IL-6 in
the cerebellum and MCP-1 and IL1β in the cerebral cortex following 10 days of ethanol
exposure (Figure 3.1H).
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Figure 3.1. Binge Ethanol Exposure Induces Neurodegeneration in the Adult
Male Mouse Brain. A, C, E. C57BL/6 male mice received water (control) or ethanol
intragastrically for 1, 5, or 10 days and brain tissues were dissected to assess the level
of cleaved caspase-3 (C-C3) and cleaved caspase-12 (C-C12) by immunoblotting. B,
D, F. The protein levels of C-C3 and C-C12 were normalized to β-actin and expressed
relative to control. Six animals (n=6) were used in each group to calculate the mean ±
SEM. *P<0.05 or **P<0.01 vs. control. G. Representative images showing FluoroJade C- (green) and NeuN- (red) positive cells in the brain of either water- or ethanoltreated mice for 10 days. H. Total RNA was prepared from the cerebellum or cerebral
cortex of water- (control) or ethanol-treated mice for 10 days to assess the level of
proinflammatory cytokines (MCP-1, TNF-α, IL-6, and IL1β) by RT-qPCR. The
mRNA level of these cytokines was normalized to 18s rRNA and expressed relative
to control. Three to six samples (n = 3-6) were used in each group to calculate the
mean ± SEM. *P<0.05 vs. control. Scale bar: 20 um.
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3.3

Binge Ethanol Exposure Induces ER Stress in the Adult Male Mouse Brain
With the same ethanol exposure paradigm, we next sought to determine whether

binge ethanol exposure induces ER stress. Consistent with the timeline of
neurodegeneration, binge ethanol exposure for 1 day did not cause a change to the levels
of ER stress markers (Figure 3.2A and B). However, ethanol exposure for 5 and 10 days
significantly increased the levels of ER stress markers including GRP78, p-eIF2α, CHOP,
XBP1s, and ATF6 both in the cerebellum and cerebral cortex (Figure 3.2C-F). As expected,
ethanol also increased the levels of ER stress markers in the liver (Figure 3.3A-B)
drastically. Oxidative stress has been suggested as a potential mechanism for ethanolinduced neurodegeneration [62, 130]. Therefore, we examined the level of oxidative stress
following binge ethanol exposure. While ethanol caused oxidative stress in the liver,
manifested by an increase of protein carbonyl and HNE adducts, it had little effect on that
in the male mouse brain (Figure 3.4A-B).
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Figure 3.2. Binge Ethanol Exposure Induces ER Stress in the Adult Male Mouse
Brain. A. C57BL/6 male mice received water (control) or ethanol intragastrically for 1
day and brains tissues were harvested to assess the level of ER stress markers by
immunoblots. B. The protein levels of ER stress markers were normalized to β-actin
and expressed relative to control. Six animals (n = 6) were used in each group to
calculate the mean ± SEM. *P<0.05 or **P<0.01 vs. control. C. C57BL/6 male mice
received water (control) or ethanol intragastrically for 5 days and brains tissues were
harvested to assess the level of ER stress markers by immunoblots. D. The protein levels
of ER stress markers were normalized to β-actin and expressed relative to control. Six
animals (n = 6) were used in each group to calculate the mean ± SEM. *P<0.05 or
**P<0.01 vs. control. E. C57BL/6 male mice received water (control) or ethanol
intragastrically for 10 days and brains tissues were harvested to assess the level of ER
stress markers by immunoblots. F. The protein levels of ER stress markers were
normalized to β-actin and expressed relative to control. Six animals (n = 6) were used
in each group to calculate the mean ± SEM. *P<0.05 or **P<0.01 vs. control.
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Figure 3.3. Binge Ethanol Exposure Induces ER Stress and Hepatocyte Death in
the Adult Male Mouse Liver. A. C57BL/6 male mice received water (control) or
ethanol intragastrically for 10 days, and the liver was dissected to assess the level of
ER stress markers, cleaved caspase-3 (C-C3) and caspase-12 (C-C12). B. The protein
levels of ER stress markers, C-C3 and C-C12, were normalized to β-actin and
expressed relative to control. Six animals (n = 6) were used in each group to calculate
the mean ± SEM. *P<0.05 or **P<0.01 vs. control.
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Figure 3.4. The Effect of Binge Ethanol Exposure on the Induction of Oxidative
Stress. C57BL/6 male mice received water (control) or ethanol intragastrically for
10 days as described in Fig. 1. The brain (cerebellum and cerebral cortex), and the
liver tissues were extracted and assayed for the level of oxidized protein (A) and
lipid peroxidation (B) as described in the Materials and Methods. The levels of
protein carbonyl or HNE-BSA were normalized to total lysates and expressed
relative to control. Three to six samples (n = 3-6) were used in each group to
calculate the mean ± SEM. *P<0.05 vs. control.
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3.4

Binge Ethanol Exposure Downregulates mTOR signaling in the Adult Male
Mouse Brain
Since there was considerable evidence of interaction between mTOR signaling and

ER stress [131], we assessed the effects of binge ethanol exposure on mTOR signaling in
the mouse brain. We found that binge ethanol exposure downregulated mTOR activity and
its downstream signaling in the mouse brain manifested by a decrease of p-mTOR, and its
target effectors, p-4EBP1, and p-p70S6K (Figure 3.5C-F). Interestingly, ethanol-induced
downregulation of mTOR signaling parallelled the induction of neurodegeneration and ER
stress; that is, ethanol-induced downregulation of mTOR was only evident after 5 days of
ethanol exposure.
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Figure 3.5. Binge Ethanol Exposure Downregulates mTOR Signaling in the
Adult Male Mouse Brain. A. C57BL/6 mice received water (control) or ethanol
intragastrically for 1 day and brains tissues were harvested to assess the activity of
mTOR signaling by immunoblots. B. The protein levels of p-mTOR and its
downstream effectors were normalized to β-actin and expressed relative to control.
Six animals (n = 6) were used in each group to calculate the mean ± SEM. *P<0.05
or **P<0.01 vs. control. C. C57BL/6 mice received water (control) or ethanol
intragastrically for 5 days and brains tissues were harvested to assess the activity of
mTOR signaling by immunoblots. D. The protein levels of p-mTOR and its
downstream effectors were normalized to β-actin and expressed relative to control.
Six animals (n = 6) were used in each group to calculate the mean ± SEM. *P<0.05
or **P<0.01 vs. control. E. C57BL/6 mice received water (control) or ethanol
intragastrically for 10 days and brains tissues were harvested to assess the activity
of mTOR signaling by immunoblots. F. The protein levels of p-mTOR and its
downstream effectors were normalized to β-actin and expressed relative to control.
Six animals (n = 6) were used in each group to calculate the mean ± SEM. *P<0.05
or **P<0.01 vs. control.
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3.5

Inhibition of ER Stress Ameliorates Ethanol-induced Neurodegeneration
To determine whether ER stress contributes to ethanol-induced neurodegeneration,

we performed in vitro experiments with a mouse neuroblastoma cell line (N2a). First, we
found that ethanol at a concentration of 0.2% or 0.4% induced ER stress and neuronal
apoptosis manifested by an increase of ER stress markers (GRP78, XBP1s, and ATF6) and
apoptotic marker (cleaved caspase-3) (Figure 3.6A, B, C, D, and F). More importantly,
cotreatment with 4-PBA, a chemical chaperone used to inhibit ER stress, abolished
ethanol-induced ER stress and neuronal apoptosis, suggesting that ER stress contributes to
ethanol-induced neurodegeneration (Figure 3.6A, B, C, D, and F). In addition, consistent
with the findings in vivo, ethanol also downregulated mTOR activity in N2a cells (Figure
3.6A and E).
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Figure 3.6. Inhibition of ER Stress Reduces Ethanol-induced Neuronal Death. A.
N2a cells were serum-starved overnight and followed by pretreatment with or without 4PBA (10 mM) for 2 hours before ethanol treatment (0.2% or 0.4%, v/v) for 12 hours. Cell
lysates were collected to assess the levels of ER stress markers and cleaved caspase-3 (CC3) by immunoblots. B-F. The protein levels of ER stress markers and C-C3 were
normalized to β-actin and expressed relative to control (without treatment by ethanol and
4-PBA). Three independent experiments (n = 3) were performed to calculate the mean ±
SEM. *P<0.05 or **P<0.01 vs. control. #P<0.05 vs. the corresponding points without 4PBA treatment.
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3.6

Inhibition of mTOR signaling Contributes to the Induction of ER Stress
To delineate the crosstalk between mTOR signaling and ethanol-induced ER stress,

we employed pharmacological approaches to intervene in mTOR signaling and ER stress
in N2a cells. TM is an ER stress inducer by inhibiting N-linked glycosylation in the
endoplasmic reticulum. TM treatment of N2A cells induced ER stress, and the induction
of ER stress was blocked by cotreatment with 4-PBA. However, both TM and 4-PBA
exerted no significant effects on mTOR signaling (Figure 3.7A-E). Likewise, although 4PBA alleviated ethanol-induced ER stress, it can not reverse ethanol-mediated
downregulation of mTOR signaling in N2a cells (Figure 3.7A and E). However, treatment
of N2A cells with rapamycin–an mTOR kinase inhibitor–inhibited mTOR signaling and
meanwhile induced ER stress (Figure 3.7F-J). Collectively, these results suggest that
mTOR signaling operates upstream of ethanol-induced ER stress and is involved in the
regulation of ER stress in response to binge ethanol exposure.
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Figure 3.7. Inhibition of mTOR Signaling Induces ER Stress. A. N2a cells were
serum-starved overnight and followed by pretreatment with or without 4-PBA (10 mM)
for 2 hours before TM treatment (0.5 or 1 ug/ml) for 12 hours. Cell lysates were collected
to assess the levels of ER stress markers and mTOR signaling. B-E. The protein levels of
ER stress markers and p-mTOR/mTOR were normalized to β-actin and expressed relative
to control (without treatment by TM and 4-PBA). Three independent experiments (n = 3)
were performed to calculate the mean ± SEM. *P<0.05 or **P<0.01 vs. control. #P<0.05
vs. the corresponding points without 4-PBA treatment. F. N2a cells were serum-starved
overnight followed by treatments with rapamycin (0, 0.5, 1, 2, 5 or 10 uM) for 12 hours
to assess the level of ER stress markers and mTOR signaling. G-J. Quantification was
normalized to β-actin and expressed relative to control (without rapamycin treatment) and
calculated as mean ± SEM for three independent experiments (n = 3). *P<0.05 or
**P<0.01 vs. control.
3.7

Effects of Binge Ethanol Exposure on Animal Behaviors
To determine whether the paradigm of binge ethanol exposure affects animal

behaviors, we evaluated locomotor activity by OFA, anxiety-like behaviors by EPM, and
spatial-based learning and memory by MWM following ethanol exposure. In OFA,
although the mice in the ethanol group showed a tendency for less activity, the total
distance traveled was not significantly different between the control group and the ethanol
group (Figure 3.8A, p=0.0697). Also, during OFA, the mice in the ethanol group spent a
similar period in the center compared with the mice in the control group (Figure 3.8B,
p=0.4717). In EPM, the ratio of open arm entries versus total entries and the total distance
traveled between the ethanol group and the control group also did not significantly differ
(Figure 3.8C, p=0.0545; Figure 3.8D, p=0.0757). Lastly, the results from the MWM test
showed there was no significant difference in term of latency or distance traveled between
the control group and ethanol group (Figure 3.8E, p=0.2816; Figure 3.8F, p=0.3285).
Altogether, these results suggest that this paradigm of binge ethanol exposure does not
cause a significant change in locomotor activity, anxiety-like behaviors, and spatial
memory and learning.
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Figure 3.8. The Effects of Ethanol-induced Neurodegeneration on Animal
Behaviors. C57BL/6 mice received water (control) or ethanol intragastrically for 10 days.
At 3 days after the last gavage, animals were subjected to OFA test (A-B) once. After 2
h following OFA, animals were subjected to EPM test once (C-D). At 5 days after the
last gavage, animals were subjected to MWM test (E-F) for 5 consecutive days.
Quantification of each parameter was calculated as the mean ± SEM of ten animals (n=10)
in each group. Unpaired student t-test was used assess the difference between control
group and ethanol group in OFA and EPM and two-way ANOVA was used in MWM to
assess the difference between two groups.
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CHAPTER 4. MANF IS NEUROPROTECTIVE AGAINST ETHANOL-INDUCED
NEURODEGENERATION VIA AMELIORATING ER STRESS
4.1

Overview
MANF was initially identified as a neurotrophic factor in search of astrocyte-

derived neurotrophic factors [91]. Meanwhile, MANF is an ER stress-inducible protein and
has been identified as a protein upregulated in myocardial infarction, cerebral ischemia,
and epilepsy in which ER stress is an underlying characteristic [92, 101, 132]. Moreover,
we recently demonstrated that MANF was induced in ethanol-induced neurodegeneration
in the developing mouse brain [115, 116]. We speculated that MANF may be associated
with ER stress regulation and thereby exert a neuroprotective role in ethanol-induced
neurodegenerative diseases. Hence, in this section, I investigated the role of MANF in ER
stress regulation and its association with ethanol-induced neurodegeneration using a thirdtrimester equivalent mouse model.
4.2

Characterization of the CNS-specific Manf Knockout Mouse Model
CNS-Manf-KO (cKO) mice exhibited a CNS-specific Manf knockout (Figure 1B).

The expression level of MANF was dramatically decreased across the entire mouse brain
compared with that in control (CTL) littermates (Manf flox/flox mice) (Figure 4.1A and B).
We also measured the body weight and brain weight and calculated the ratio of brain weight
to body weight in cKO mice and CTL littermates. In brevity, the cKO mouse brain and
body tended to weigh less compared with those in the CTL group (Figure 4.1C and 1D).
However, the ratio of brain weight to body weight between these two groups showed no
significant difference (Figure 4.1E). It is noteworthy that the bodyweight difference can
extend to the adult stage (Figure 4.1F). We think the decrease in body weight and brain
weight is likely due to the involvement of MANF in neuronal development and energy
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metabolism.

Figure 4.1. Characterization of the CNS-specific Manf Knockout Mouse
Model. A. Representative immunoblots of MANF in cerebral cortex (CC),
cerebellum (CB), subcortical structure (SC), liver and heart in the control (CTL)
and Manf conditional knockout (cKO) mice. B. Representative immunochemical
staining of MANF in CC, HP (hippocampus) and CB sections of PD7 pups from
the CTL and cKO groups. Scale bar: 20um. C-F. Measurement and calculation of
brain weight (C) and body weight (D and F) and the ratio of brain weight to body
weight (E) in the CTL and cKO mice. PD: postnatal day. PM: postnatal month.
Mean ± SEM. n=8-11 per group, **p<0.01 or ***p<0.001 vs. CTL.
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4.3

MANF Deficiency Exacerbates Ethanol- and TM- induced Neuronal Apoptosis
in the Developing Mouse Brain
First, we determined the effects of MANF deficiency on neuronal apoptosis and ER

stress at basal conditions (without ethanol or TM treatment). On postnatal day (PD) 6, pups
were sacrificed, and the brains were dissected to compare the levels of neuronal apoptosis
and ER stress between the CTL group and cKO group. There was no significant induction
of neuronal apoptosis (Figure 4.2A and B) even though we found a slight induction of ER
stress in the brain of cKO mice (data not shown). To investigate its effects on ethanolinduced neuronal apoptosis, a modified neonatal ethanol exposure paradigm was employed
[133]. Blood ethanol concentration was first measured to be around 185 ± 10 mg/dl in
ethanol-injected group as compared to 7.5 ± 1.4 mg/dl in the PBS-injected group (data not
shown). While ethanol exposure alone resulted in neuronal apoptosis to a certain degree in
the developing mouse brain, we found that MANF deficiency can dramatically promote
ethanol neurotoxicity (Figure 4.2C and D). Co-labelling with TUNEL and NeuN (a neuron
marker) revealed that almost all of the apoptotic cells were neurons (Figure 4.2E). The
apoptotic neurons, in general, spread across the entire brain, but some regions (e.g., frontal
cortex, cerebellum, thalamus, and hippocampus), indeed, showed more vulnerability
(Figure 4.2D). To investigate whether the effects of MANF are ubiquitous to all ER stresscharacterized neurodegenerative diseases, we treated the mice with a generic ER stress
inducer, TM (3mg/kg, 30% solution in dextrose) following the same procedure except that
the treatment duration was 24 hours. The results presented a similar pattern showing that
MANF deficiency exacerbated TM-induced neuronal apoptosis, especially in the frontal
cortex, cerebellum, and hippocampus (Figure 4.2F and G). Taken together, these results
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suggest that MANF is neuroprotective against ethanol-induced neuronal apoptosis and that
the neuroprotective effects of MANF likely apply to ER stress-characterized
neurodegenerative diseases.
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Figure 4.2. MANF Deficiency Exacerbates Ethanol- and TM-induced Neuronal
Apoptosis. A. Representative immunoblots of cleaved caspase 3 (Cl. Casp 3) in cerebral
cortex (CC), cerebellum (CB) and subcortical structure (SC) in the CTL and cKO mice. B.
Representative immunochemical staining of Cl. Casp 3 in CC, HP (hippocampus) and CB
sections of PD7 pups from the CTL and cKO groups. Scale bar: 20um. C. Representative
immunoblots of MANF and cleaved caspase 3 (Cl.Casp3) in cerebral cortex (CC) and
cerebellum (CB) of PD7 pups from the control (CTL/PBS and CTL/EtOH) and cKO
(cKO/EtOH) groups. Mean ± SEM. n=3-5, *p<0.05 or **p<0.01 vs. CTL/PBS. #p<0.05 or
##p<0.01 vs. CTL/EtOH. Scale bar: 20um. D. Representative immunochemical staining of
Cl.Casp3 in CC, HP (hippocampus), and CB sections of PD7 pups from the control
(CTL/EtOH) and cKO (cKO/EtOH) groups. E. Representative images of co-labeling with
TUNEL (green) and NeuN (red) in CC, CA1, and CB sections of PD7 pups from the cKO
group. F. Representative immunoblots of MANF and Cl. Casp3 in cerebral cortex (CC) and
cerebellum (CB) of PD7 pups from the control (CTL/mock and CTL/TM) and cKO
(cKO/TM) groups. Mean ± SEM. n=3-5, *p<0.05 or **p<0.01 vs. CTL/mock. #p<0.05,
##p<0.01 or ###p<0.001 vs. CTL/TM. G. Representative staining of Cl.Casp3 in CC, CA1,
and CB sections of PD7 pups from the control (CTL/TM) and cKO (cKO/TM) groups.

4.4

MANF Deficiency Exacerbates Ethanol- and TM- induced ER Stress in the
Developing Mouse Brain
To determine whether the resulting increase of neuronal apoptosis is attributed to

ER stress over-activation, we examined ER stress levels in the entire mouse brain and
compared that level between CTL pups and cKO pups following the same treatment and
procedure. Consistent with our previous results, we found a moderate increase in ER stress
due to ethanol or TM exposure alone (Figure 4.3A and D). However, we found MANF
deficiency potentiated ethanol- or TM-induced ER stress significantly, i.e., causing a
further dramatic enhancement of ER stress in the cerebral cortex, cerebellum, and
hippocampus of the mouse brain. This data suggest that MANF may function as an ER
stress-buffering agent and the deficiency of MANF exacerbates ethanol- or TM-induced
ER stress (Figure 4.3A-E).
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Figure 4.3. MANF Deficiency Exacerbates Ethanol- and TM-induced ER Stress.
A. Representative immunoblots of ER stress markers (GRP78, CHOP, XBP1s and
ATF6) in the entire brains of PD7 pups from control (CTL/PBS and CTL/EtOH) and
cKO (cKO/EtOH) groups. Mean ± SEM. n=3-5, *p<0.05 or **p<0.01 vs. CTL/PBS.
#p<0.05 vs. CTL/EtOH. B. Representative immunochemical staining of CHOP (red)
and DAPI (blue) in CC, CA1, and CB sections of PD7 pups from control (CTL/EtOH)
and cKO (KO/EtOH) groups. C. Representative images of co-labeling with TUNEL
(green) and CHOP (red) in CC, CA1, and CB sections of PD7 pups from the
cKO/EtOH group. D. Representative immunoblots of ER stress markers (GRP78,
CHOP, XBP1s and ATF6) in the entire brains of PD7 pups from control (CTL/mock
and CTL/TM) and cKO (cKO/TM) groups. Mean ± SEM. n=3-5, *p<0.05 vs.
CTL/mock. #p<0.05 or ##p<0.01 vs. CTL/TM. E. Representative staining of CHOP
(brown) and Hematoxylin (blue) in CC, CA1, and CB sections of PD7 pups from
control CTL/TM and cKO/TM groups.

62

4.5

Blocking ER Stress Abrogates the Deleterious Effects of MANF Deficiency on
Ethanol- and TM-induced Neuronal Apoptosis
We hypothesized that the increase of neuronal apoptosis due to MANF deficiency

was attributed to the exacerbation of ER stress. First, co-labeling with TUNEL and CHOP
(an ER stress marker) revealed that most apoptotic labeling co-localized with ER stress
labeling, indicating that ER stress may be correlated with neuronal apoptosis (Figure 4.3C).
This hypothesis was also supported by the employment of the ER stress blocker–4-PBA.
4-PBA, as an ER stress blocker, is a chemical chaperone that has been widely used to
prevent ER stress in the liver, adipose tissue, and brain. In our animal model, pretreatment
with 4-PBA can block ethanol- and TM- induced ER stress both in the CTL group and cKO
mice (Figure 4.4A and C). Meanwhile, ethanol- and TM- induced neuronal apoptosis was
also abolished by the employment of 4-PBA (Figure 4.4 A, B, C, and D). Collectively, this
data suggests that the overactivation of ER stress is accountable for the exacerbation of
neuronal apoptosis. It is also noteworthy that, in this study, we intentionally reduced the
dose of ethanol or TM which was used in our previous study so that ethanol- or TMinduced neuronal apoptosis and ER stress was not saturated and the effects of MANF
deficiency can be detected.
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Figure 4.4. Blocking ER Stress Abrogates the Deleterious Effects of MANF
Deficiency on Ethanol- and TM-induced Neuronal Apoptosis. A.
Representative immunoblots of ER stress markers and Cl. Casp 3 in the entire
brains of PD7 pups from the control (CTL/EtOH and CTL/EtOH/4-PBA) and cKO
(cKO/EtOH and cKO/EtOH/4-PBA) groups. Mean ± SEM. n=3-5, *p<0.05 or
**p<0.01 vs. corresponding treatment control (CTL/EtOH or cKO/EtOH) groups.
#p<0.05 or ##p<0.01 vs. CTL/EtOH. B. Representative images of TUNEL (green)
and DAPI (blue) labeling in CC, CA1, and CB sections of PD7 pups from
cKO/EtOH and cKO/EtOH/4-PBA groups. Scale bar: 20um. C. Representative
immunoblots of ER stress markers and Cl.Casp3 in the entire brains of PD7 pups
from control (CTL/TM and CTL/TM/4-PBA) and cKO (KO/TM and KO/TM/4PBA) groups. Mean ± SEM. n=3-5, *p<0.05 or **p<0.01 vs. corresponding
treatment control (CTL/TM or KO/TM) groups. #p<0.05 or ##p<0.01 vs. CTL/TM.
D. Representative images of TUNEL (green) and DAPI (blue) labeling in CC, CA1,
and CB sections of PD7 pups from cKO/TM and cKO/TM/4-PBA groups. Scale
bar: 20um.
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4.6

Potential Targets of MANF that Mediate the Regulation of ER Stress
As described in the section of the method, we first ran RSEM analysis to obtain the

reads that can be mapped out. The abundance of these transcripts was expressed as
transcripts per million (TPM). As shown in Table 4.1, more than 98 percent of reads were
mapped, and more than 90 percent of reads were uniquely mapped; only a few portions
(less than five percent) were mapped to multiple loci. From the RSEM results, we ran an
EBseq analysis that gave us a list of genes differentially expressed (DE) between the CTL
group and the cKO group. A total of 2212 DE genes were detected (not shown here);
however, only 933 had identified IDs for them (not shown here). From the list of DE genes,
we performed a gene ontology enrichment analysis (GOEA) that assigned DE genes to
their associated signaling pathways. The 933 genes are associated with many signaling
pathways with protein processing in endoplasmic reticulum being one of them. A total of
18 DE genes were identified to be associated with protein assessing in the endoplasmic
reticulum (Table 4.2 and Figure 4.5). Among these 18 genes, most of them were
upregulated by Manf cKO; three genes (EDEM3, UBE2J2, and UBXN6) were
downregulated in the brain of Manf cKO mice (Table 4.2 and Figure 4.5A). In term of gene
function, eight genes (PDIA3, HSPA5, PDIA6, DDOST, PDIA4, HSP90B1, DNAJC3, and
HYOU1) are associated with protein chaperoning function or protein folding, seven genes
(EDEM3, UBE2J2, ERLEC1, SELENOS, UGGT1, UBXN6, and ATF4) are associated
with protein quality control or ER-associated degradation, whereas three genes (RRBP1,
SEC61A1, and SEC24D) are mainly involved in protein trafficking or secretory pathways.
Next, we verified those DE genes that showed more than 1.5 folds change between the
CTL group and the cKO group and confirmed Manf cKO in the cKO group by RT-qPCR
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(Figure 4.5B-H). As expected, Manf mRNA level is significantly reduced in the brain of
Manf cKO mice (Figure 4.5B). Overall, the results are consistent with our RNA-Seq data
reflecting the same change of those targets in the Manf cKO group (Figure 4.5C-H).
However, we did find that the expression level of HSPA5 and ERLEC1 does not differ
significantly between the control group and Manf cKO group (Figure 4.5E and F). In
summary, the RNA-Seq results further demonstrated that MANF is likely an ER stressbuffering agent to ameliorate ER stress and that MANF deficiency causes a deterioration
of ER stress.
Table 4.1. RNA-Seq Read Mapping Summary
Samples

Input Reads

Uniquely

Reads

Reads

Mapped

Mapped to

Unmapped

Reads (%)

Multiple

(%)

Total (%)

Loci (%)
CTL1

24426184

92.89%

4.43%

1.58%

98.90%

CTL2

32792469

93.23%

3.96%

1.69%

98.88%

CTL3

24967970

92.70%

4.46%

1.73%

98.89%

cKO1

26898333

93.52%

4.06%

1.25%

98.83%

cKO2

28616373

91.83%

4.53%

2.52%

98.88%

cKO3

24953320

93.36%

3.94%

1.57%

98.87%
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Table 4.2. DE Genes that Are Involved in Protein Processing in the ER

Gene Symbols

TPM CTL

TPM cKO

Fold

CTL1

CTL2

CTL3

cKO1

cKO2

cKO3

Change*

EDEM3

10.59

0

0

0

0.03

0

-353

PDIA3

178.25

194.95

198.1

236.47

229.3

245.79

1.25

HSPA5

190.45

210.63

200.87

325.24

321.53

373.94

1.70

RRBP1

0

0

0

5.73

0

0

3549

UBE2J2

3.62

2.7

0.56

0

0

0

-2870

PDIA6

106.21

125.87

111.92

168.65

177.94

175.76

1.52

DDOST

74.59

78.86

81.03

100.56

109.77

114.31

1.38

PDIA4

64.16

67.02

72.67

88.98

85.02

91.26

1.30

HSP90B1

281.12

335.28

308.45

463.05

428.79

472.81

1.48

DNAJC3

27.04

32.01

28.88

45.9

34.96

42.65

1.40

SEC61A1

77.17

81.16

81.32

96.02

94.07

105.29

1.23

ERLEC1

6.58

11.19

10.87

14.79

14.02

16.97

1.60

SELENOS

32.21

39.69

36.44

54.88

50.98

45.98

1.40

HYOU1

0

0

0

10.12

8.6

12.97

17439

SEC24D

10.82

15.53

15.35

19.93

19.17

19.79

1.41

UGGT1

14.51

16.23

16.71

20.55

19.63

24.6

1.37

UBXN6

8.03

6.79

4.52

0

0

0

-3004

ATF4

105.87

134.57

107.86

157

149.97

156.83

1.33
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*, - and + indicate down- and up-regulation, respectively.

Figure 4.5. Verification of DE Genes that Are Associated with Protein Processing
in ER. A. Heat map representing color-coded DE genes that are associated with protein
processing in ER. B-H. Verification of DE genes that are associated with protein
processin in ER by RT-qPCR. Mean ± SEM. n=3, *P<0.05 or **P<0.01 vs. CTL.
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CHAPTER 5. MANF IS INVOLVED IN NEUROGENESIS
5.1

Overview
Neurogenesis is regulated at multiple levels, including NSC proliferation,

differentiation, and the survival and maturation of newly born neurons [102]. Many
signaling pathways, growth factors, cytokines, neurotransmitters, and neurotrophic factors
are involved in this complex regulation of neurogenesis [102]. Ethanol exposure can inhibit
or promote neurogenesis depending on animal models and ethanol exposure paradigm, e.g.,
acute ethanol exposure or chronic ethanol exposure [108]. Because MANF responds to
ethanol exposure and has been reported to improve the survival of embryonic midbrain
dopaminergic neurons both in vivo and in vitro [91, 96, 115], we speculated that MANF
may participate in or affect the process of neurogenesis. Therefore, in this section, I
explored the role of MANF in neurogenesis in mouse brains.
5.2

MANF Deficiency Enhances Neurogenesis in the SGZ of the Hippocampal
Dentate Gyrus
Neurons born in the SGZ can migrate to the granule cell layer and eventually

differentiate into granule cells in the hippocampal dentate gyrus [102]. We evaluated the
neurogenesis/proliferation level in SGZ by immunostaining of DCX and BrdU
incorporation. DCX is a microtubule-associated protein expressed in neuronal precursor
cells and immature neurons [134]. BrdU is an analog of the nucleoside thymidine that can
be incorporated into the genome during DNA replication; BrdU labeling is a classical
method used for labeling dividing neurons [135]. We first assessed the neurogenesis level
in SGZ at the postnatal stage and compared the level between the CTL group and the cKO
group. As shown in Figure 5.1A and 5.1C, there was a significant increase in neurogenesis
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in the SGZ of cKO mice when compared to their CTL littermates. Interestingly, this
enhancement of neurogenesis in the SGZ of cKO mice extended to the adult stage, e.g., in
three month- or six-month-old mice (Figure 5.1A). However, we did not observe a
significant change in neurogenesis in the SGZ of ten-month-old cKO mice when compared
to the neurogenesis level in CTL group mice. The effects of MANF on neurogenesis may
reflect the expression pattern of MANF that presents a robust expression at an early age
during brain development and declines afterward.

70

Figure 5.1. MANF Deficiency Enhances Neurogenesis in the SGZ of the
Hippocampal Dentate Gyrus. A. Representative co-immunostaining of DCX
(green) and NeuN (red) in the hippocampal dentate gyrus sections from the CTL
(a, c, e and g) and cKO (b, d, f and h) mice. PD: postnatal day. M: postnatal month.
B. Quantification of DCX positive cells in the SGZ of CTL and cKO mice. C.
Representative images of co-labeling with calbindin (green) and BrdU (red) in the
hippocampal dentate gyrus sections of PD7 pups from CTL (i) and cKO (j) groups.
D. Quantification of BrdU positive cells in the SGZ of PD7 pups from CTL and
cKO mice. Scale bar: 20um. Mean ± SEM. n=3-5, *P<0.05 vs. CTL.
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5.3

MANF Deficiency Enhances Neurogenesis in the SVZ of the Anterior Lateral
Ventricles
Neurons born in the SVZ can migrate through the RMS and eventually evolve into

granule neurons and periglomerular neurons in the olfactory bulb [102]. We evaluated
neurogenesis/proliferation level in the SVZ by immunostaining of Ki-67 and BrdU
incorporation. Ki-67 is a general cell proliferating marker and has been widely used as a
proliferating marker in cancer biology and neuroscience [135]. Consistent with the uptrend
of neurogenesis in the SGZ of the hippocampal dentate gyrus of cKO mice, neurogenesis
was also increased in the SVZ of the anterior lateral ventricles of cKO mice at the postnatal
stage (Figure 5.2A and 5.2C). Similarly, this increase of neurogenesis in SVZ remained at
the early adult stage, e.g., in three-month or six-month-old mice, but disappeared in the late
adult stage, e.g., in ten-month-old mice (Figure 5.2A).
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Figure 5.2. MANF Deficiency Enhances Neurogenesis in the SVZ of the
Anterior Lateral Ventricles. A. Representative immunochemical staining of Ki67 in the lateral ventricle sections from the CTL (a, c, e and g) and cKO (b, d, f and
h) mice. PD: postnatal day. M: postnatal month. B. Quantification of Ki-67 positive
cells in the SVZ of CTL and cKO mice. C. Representative images of co-labeling
with calbindin (green) and BrdU (red) in lateral ventricles sections of PD7 pups
from the CTL (i) and cKO (j) groups. D. Quantification of BrdU positive cells in
the SVZ of PD7 pups from CTL and cKO mice. Scale bar: 20um. Mean ± SEM.
n=3-5, *P<0.05 vs. CTL.
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5.4

MANF Deficiency Promotes NeuroD1 and Sox2 Expression and Cell Cycle
Progression
Over the past decades, many proteins have been identified to express at specific

stages during the process of neurogenesis and lineage commitment. Of which, most
proteins are transcriptional factors that control lineage progression at the transcriptional
level in neurogenesis [103]. Among them, the SRY-related high-mobility group box (Sox)
family member Sox2 and NeuroD1 appear to be the most predominant transcriptional
factors that maintain the multipotency and proliferative capacities of NSCs [103]. We have
examined the protein levels of NeuroD1 and Sox2 in the Manf cKO mouse brain and
compared with that in the CTL mice. Our results showed that MANF deficiency increased
the expression of NeuroD1 and Sox2, suggesting that neurogenesis is increased in Manf
cKO mice (Figure 5.3). Sox2 controls the expression of several target genes; among them,
the nuclear orphan receptor, Tlx, is positively regulated by Sox2. Tlx can promote
proliferation and self-renewal of NSCs either by activating canonical Wnt pathway or by
inhibiting pathways that maintain cell quiescence. We have examined a number of cellcycle markers and cell-cycle inhibitors that are involved in cell quiescence. As shown in
Figure 5.3, cell-cycle inhibitor (p15 and p27) were downregulated in the brain of Manf
cKO mice. Consistent with these findings, mitotic markers present in the G2/M phase
(cyclin A2 and pHH3) were increased, whereas the quiescent phase marker (cyclin E1) was
decreased. Collectively, these findings are consistent with the results

from

immunochemical staining of DCX and Ki-67, suggesting that neurogenesis is elevated in
MANF deficient mice and the increase of neurogenesis may be partly attributed to the
acceleration of cell cycle progression.
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Figure 5.3. MANF Deficiency Promotes NeuroD1 and Sox2 Expression and
Cell Cycle Progression. Representative immunoblots (A) and quantification (B)
of NeuroD1, Sox2 and cell cycle inhibitors as well as markers in the brains of the
CTL and Manf cKO mice. Mean ± SEM. n=3-5, *P<0.05 or **P<0.01 vs. CTL.
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5.5

Gain-of-function of MANF Retards Cell Cycle Progression in vitro
To consolidate our findings in vivo, we have examined the effects of the gain-of-

function of MANF on cell proliferation in vitro. N2A cells were infected with AD-MANF
to obtain MANF overexpression in comparison with cells infected with AD-CTL (ADvector). First, we confirmed the overexpression of MANF in these cells by immunoblots
and immunochemical staining of MANF and HA 48 hours after viral infection (Figure 5.4A
and 5.4B). Cell cycle analysis by flow cytometric measurements of propidium iodide (PI)
incorporation in DNA revealed a smaller percentage of proliferative cells (the summation
of S phase and G2/M phase) in AD-MANF infected cells when compared to that in ADCTL infected cells (Figure 5.4C). The results were supported by a decrease of S phase or
G2/M phase marker (cyclin A2, PCNA, and pHH3) and an increase of cell cycle inhibitors
(p15 and p27) in AD-MANF infected cells (Figure 5.4D). MTT assay is a commonly used
method to evaluate cell viability or proliferation by measuring cell metabolic activity. The
results by MTT assay suggest that the gain-of-function of MANF decreases cell viability
or proliferation (Figure 5.4E).
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Figure 5.4. Gain-of-function of MANF Retards Cell Cycle Progression in N2A
Cells. N2A cells were infected with AD-MANF or AD-CTL viral particles as described
in “materials and methods”. A-B. 48 hours after infection, MANF overexpression was
confirmed by co-labeling of MANF (green) and HA (red) as well as DAPI (blue) (A)
and immunoblotting of MANF and HA (B) in these two AD-infected cell lines. C. Flow
cytometric analysis of PI content was performed for cell cycle analysis and the
proliferative phases (S+G2/M) was quantitated in these two infected cell lines. D.
Representative immunoblots and quantification of cell cycle markers (PCNA, p-HH3
andcyclin A2) and cell cycle inhibitors (p15 and p27) in these two AD-infected cell
lines. E. Cell viability measured by MTT assay was quantificated and expressed relative
to control (AD-CTL). Three independent experiments (n = 3) were performed to
calculate the mean ± SEM. *P<0.05 or **P<0.01 vs. AD-CTL.
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5.6

Loss-of-function of MANF Promotes Cell Cycle Progression in vitro
To investigate the effects of the loss-of-function of MANF on cell proliferation in

vitro, we have developed several colonies in which Manf was knocked out in N2A cells
using the CRISPR/Cas9 method. First, we confirmed that MANF was knocked out with a
representative colony by immunoblots and immunochemical staining of MANF (Figure
5.5A and 5.5B). Consistent with the finding in N2A cells with MANF overexpression,
Manf deletion in N2A increased the percentage of proliferative cells (the summation of S
phase and G2/M phase) (Figure 5.5C). Likewise, this increase of proliferation was
supported by an increase of S phase or G2/M phase marker (cyclin A2, PCNA, and p-HH3)
and a decrease of cell cycle inhibitors (p15 and p27) in Manf knockout N2a cells (Figure
5.5D). Taken together, the results indicate that the gain-of-function of MANF retards cell
cycle progression, whereas the loss-of-function of MANF promotes cell proliferation. The
inhibition of cell cycle progression could be the mechanism that underlies the increase of
neurogenesis in the Manf cKO mice.
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Figure 5.5. Loss-of-function of MANF Promotes Cell Cycle Progression in
N2A Cells. Several colonies in which Manf is knocked out using CRISPR/Cas9
method were developed as described in “materials and methods”. A-B.
Representative images of co-labeling of MANF (green) and DAPI (blue) (A) and
immnunoblots of MANF in a representative colony (B) in comparison with that in
a colony transfected with the control plasmid. C. Flow cytometric analysis of PI
content was performed for cell cycle analysis and the proliferative phases
(S+G2/M) was quantificated in these cells. D. Representative immunoblots and
quantification of cell cycle markers (PCNA, p-HH3 and cyclin A2) and cell cycle
inhibitors (p15 and p27) in these cells. Three independent experiments (n = 3) were
performed to calculate the mean ± SEM. *P<0.05 or **P<0.01 vs. CTL.
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CHAPTER 6. DISCUSSION
6.1

ER Stress and Ethanol-induced Neurodegeneration
According to the survey on ethanol use worldwide in 2018, men tend to drink more

and are more often current drinkers than women [4]. In my first project, the effects of binge
ethanol drinking on neurodegeneration and ER stress were evaluated in adult male mice.
We

demonstrated

that

binge

ethanol

exposure

caused

duration-dependent

neurodegeneration, neuroinflammation, and ER stress in the cerebellum and cortex of the
adult mouse brain. However, this paradigm of ethanol exposure did not cause significant
alterations in behavioral outcomes which were tested by OFA, EPM, and MWM. In vitro,
our studies suggest that mTOR signaling mediates the induction of ER stress that
contributes to ethanol-induced neuronal cell death.
This paradigm of binge ethanol exposure results in high BECs (300-400 mg/dl).
Although NIAAA defines binge drinking as a pattern of drinking that leads to a BEC of 80
mg/dL, the actual amount of ethanol consumed in human alcoholics is much higher. BECs
greater than 300 mg/dl are not uncommon in human alcoholics [136-139]. Some alcoholics
with a BEC larger than 400 mg/dL are coherent and able to drive and BECs greater than
500 mg/dL were reported in heavy drinkers [136, 139]. The paradigms of binge ethanol
exposure similar to ours have been used to investigate ethanol-induced neurodegeneration,
glial activation, and neuroinflammation in the brain of adult and adolescent mice [63, 64,
140].
Multiple mechanisms have been proposed for ethanol-induced neurodegeneration,
including neuronal excitotoxicity, oxidative stress, and proinflammatory response [141,
142]. In our binge ethanol drinking mice, ethanol causes little oxidative stress in the brain,
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although it induces significant oxidative stress in the liver. However, we found that IL-6 in
the cerebellum and MCP-1 and IL1β in the cerebral cortex are induced by ethanol
exposure, suggesting that proinflammation occurs in the mouse brain. These
proinflammatory cytokines may partially contribute to ethanol-induced neurodegeneration.
ER stress is a hallmark and an underlying mechanism of many neurodegenerative diseases.
We showed that binge ethanol exposure induces ER stress manifested by an increase of ER
stress markers, such as GRP78, p-eIF2, CHOP, ATF6, and XBP1s. Interestingly, the
timeline of ethanol-induced ER stress is correlated well with that of ethanol-induced
neurodegeneration. Moreover, ethanol activates an ER-resident caspase, caspase-12, which
is usually activated by ER stress [129, 143]. Cleaved caspase-12 may activate other
caspases including caspase-3, and caspase-9 to induce cell apoptosis [144, 145]. The
activation of caspase-12 led us to hypothesize that ER stress may be involved in ethanolinduced neurodegeneration. This hypothesis is supported by our in vitro study showing that
4-PBA, an ER stress inhibitor, significantly reduces ethanol-induced ER stress as well as
the death of neuronal cells. Together, these data suggest that ER stress at least partially
mediates ethanol-induced neurodegeneration.
The effect of ethanol on ER stress in the mature brain is different from that in the
developing brain. Our previous study indicated that ethanol rapidly triggers
neurodegeneration and ER stress in the developing brain; ethanol-induced ER stress in the
neonatal brain is evident after 4-8 hours of exposure and a drastic caspase-3 activation and
neurodegeneration are observed after 8 hours of exposure [115]. In the adult brain,
however, ethanol-induced neurodegeneration and ER stress are only found after 5 days of
exposure to a much lesser extent. These results imply that the adult brain has a more mature
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UPR system that can better cope with ER stress.
The underlying mechanisms for ethanol-induced ER stress are unclear.
Acetaldehyde, a metabolite of ethanol can form adducts with proteins, nucleic acids, and
lipids, which may affect protein folding [146]. Ethanol can also cause dysregulation of Ca2+
homeostasis in the ER and consequently results in dysfunction of Ca2+-dependent
chaperones or enzyme that leads to ER stress [146]. Additionally, ethanol metabolism
generates ROS and thereby disrupts the redox status in the ER that leads to ER stress [146].
Neuroinflammation has also been shown to initiate ER stress in the brain [147-149]. mTOR
belongs to the family of serine/threonine kinases. It exists in two complexes, mTORC1 and
mTORC2, that have different subunit compositions and undertake distinct cellular tasks
[131]. It has been reported that ethanol downregulates mTOR signaling to promote
autophagy in the developing brain, and cultured astrocytes and neurons [150, 151]. The
current study showed that binge ethanol exposure downregulates mTOR signaling both in
vivo and in vitro. However, we did not observe a significant increase in autophagy in the
brain following ethanol exposure (data not shown). Instead, inhibition of mTOR signaling
by rapamycin induces ER stress in neuronal cells, whereas inhibition or activation of ER
stress can not reverse ethanol-induced inhibition of mTOR signaling. This data suggests
that mTOR signaling is upstream of ethanol-induced ER stress and ER stress may act as a
hub that converges signals from inflammatory response, oxidative stress, and mTOR
signaling.
While the effects of binge ethanol exposure on behavioral deficits in rats were well
discussed in previous studies [37, 152, 153], only a few studies focused on binge ethanol
exposure-induced behavioral deficits in adult mice. Some studies showed that binge
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ethanol exposure can lead to behavioral deficits, such as impaired spatial learning and
memory, particularly in adolescent rats [154, 155]. However, we did not observe
significant behavioral alterations in our ethanol gavaged mice. There are several
possibilities for this finding. First, the extent of neurodegeneration under this ethanol
paradigm might be not adequate to elicit behavioral alterations. Second, ethanol-induced
changes in behaviors might be recovered because the current behavioral tests were
performed 3-5 days after ethanol exposure. Third, depending on the animal model and
timing/dosage of ethanol exposure, ethanol can also induce neurogenesis during or after
ethanol exposure [111, 156]. Our results showed binge ethanol exposure increased
neurogenesis/proliferation in the subgranular zone and subventricular zone after 10 days
of ethanol exposure (data not shown), manifested by the increase of doublecortin (DCX)
and Ki-67. The new neurons produced by the increase of neurogenesis may compensate
for the neuronal deficit elicited by binge ethanol exposure.
In summary, binge ethanol exposure induces ER stress and neurodegeneration in
adult mice. The induction of ER stress contributes to ethanol-induced neurodegeneration.
Mechanistically, ethanol-induced ER stress is regulated at least partially by mTOR
signaling. It remains to be revealed whether ER stress indeed contributes to ethanolinduced neurodegeneration in vivo. Additionally, the mechanisms for ethanol-induced ER
stress have not been completely elucidated. For example, the pathways/intermediates
bridging mTOR signaling and ER stress are unknown. Also, does ethanol-induced
neuroinflammation contribute to the induction of ER stress or vice versa? A better
understanding of the role of ER stress in ethanol-induced neurodegeneration may offer
novel approaches in the prevention and treatment of ethanol-associated neurotoxicity.
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6.2

MANF, ER Stress, and Ethanol-induced Neurodegeneration
In my second project, using a third-trimester equivalence mouse model and a CNS-

specific Manf knockout mouse model, we have demonstrated that MANF is
neuroprotective against ethanol-induced neurodegeneration through ameliorating ER stress
and the neuroprotective role of MANF is likely applied to other ER stress-characterized
neurodegenerative diseases. Moreover, the results from a whole transcriptome RNA
sequencing on brain samples from Manf cKO mice and control mice provide evidence
about the involvement of MANF in ER stress regulation and shed light on the potential
targets that mediate the ER stress-buffering capacity of MANF in ethanol-induced
neurodegeneration.
A third-trimester equivalent mouse model is used in our study to mimic prenatal
ethanol exposure that typically occurs in FASDs. Due to a developmental timing shift
between humans and rodents, the developmental period of the rodent brain in PD 1-10 is
equivalent to the third trimester in humans when brain growth spurt occurs [157]. The
original model was established by Olney’s group and then became widely used to induce
neurodegeneration in infant mice [133]. We modified the dose applied to infant mice from
5 g/kg to 3g/kg. We found this dose resulted in a BEC of 185 ± 10 mg/dl and minimal
neuronal apoptosis in control mice. As discussed in Section 6.1, we believe the BEC in the
modified ethanol exposure paradigm is more relevant to alcoholic drinking during
pregnancy and more importantly, the resulting neuronal apoptosis is not saturated so that
the exacerbating effects of MANF deficiency on neuronal apoptosis can be detected.
Besides, we choose to investigate the role of MANF in ethanol neurotoxicity in the
developing brain for the following two reasons. First, the expression level of MANF varies
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over time during brain development; it has its highest expression during the developmental
stage and declines afterward. We believe that the beneficial effects of MANF on ER stress
and ethanol-induced neurodegeneration is more predominant in the developing brain than
in the mature brain. Second, as discussed in Section 6.1, ER stress is responsive to ethanol
exposure in the developing brain to a greater extent than in the mature brain.
We have investigated the effects of MANF on ER stress and neurodegeneration not
only in ethanol-induced neurodegeneration but also in TM-induced neurodegeneration. TM
is a widely used ER stress inducer by blocking N-linked glycosylation in the ER. Similar
effects were present in both pathological conditions showing that MANF deficiency
exacerbates ER stress and neurodegeneration, which suggests that the beneficial effects of
MANF may be ubiquitous to all ER stress-characterized neurodegenerative diseases.
Nevertheless, we did observe some differences regarding the types of cells that were
undergoing apoptosis between these two conditions. It appeared that most of the apoptotic
cells in TM-induced neurodegeneration are immature neurons as opposed to the apoptotic
cells being mature neurons in ethanol-induced neurodegeneration. Since MANF is widely
expressed both in neurons and glial cells and the beneficial effects of MANF are likely
applied to all brain cells. Hence, we speculate that the treatments (ethanol or TM) determine
cell-type-specific toxicity. Although MANF deficiency can exacerbate their harmful
effects, it remains aligned with their toxic specificity.
MANF is an ER-resident protein even though secretory MANF has been identified
in circulation and interstitial tissue [97]. It is well established that MANF is an ER stressresponsive protein, induced mainly through transcriptional activation by ATF6 [132]. Our
results indicate that MANF functions as an ER stress-buffering agent to ameliorate ER
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stress and as a result, MANF deficiency causes a deterioration of ER stress. While the exact
mechanisms that underlie the buffering effects of MANF on ER stress remain unclear,
several mechanisms have been proposed. A study recently reported that the SAP domain
of MANF interacts with BiP, antagonizing BiP-mediated nucleotide change, and thereby
stabilizes BiP-client complexes to facilitate protein folding [158]. Second, MANF contains
a C-XX-C motif and has been reported to be involved in disulfide bond formation, a critical
step in protein folding in the ER [94]. Alternatively, one group demonstrated that MANF
is a structurally unique redox-sensitive chaperone that can restore protein folding in the
ischemic heart [159].
Our RNA sequencing data further confirmed the involvement of MANF in ER
stress regulation. Apart from the ER stress markers examined by immunoblots, it has
identified a number of targets that are ER-resident protein responsible for the folding and
trafficking of newly synthesized protein. These targets carry on a series of functions
ranging from protein chaperoning to protein disulfide isomerization. It should be noted that
these proteins could be direct targets of MANF or indirect targets that are indicative of the
deterioration of ER stress. Of note, most of the upregulated transcripts are ER-resident
chaperones or protein disulfides (PDIs) that can improve an adaptation to ER stress,
whereas most of the downregulated transcripts (UBE2J2 and UBXN6) are ubiquitinconjugating enzymes that are involved in proteasomal degradation [160, 161]. We
speculate that MANF deficiency may disrupt the ubiquitination system and consequently
causes ER stress manifested by an abrupt increase of ER stress-related transcripts. Further
experiments are needed to identify their physical interaction and functional connection with
MANF.
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In summary, we have provided evidence, with loss-of-function of MANF, that
MANF is neuroprotective against ER stress-characterized neurodegenerative disease
through ameliorating ER stress. Nevertheless, direct evidence about the effects of MANF
on ethanol- or TM- induced ER stress and neurodegeneration from the gain-of-function of
MANF is needed to draw a clear-cut conclusion. Besides, although MANF is an ERresident protein, it can also secrete out of cells in stressful conditions [162]. Therefore,
future studies are needed to examine the potential distinct function of intracellular MANF
and extracellular MANF. Lastly, MANF is expressed in both neurons and glial cells. Our
preliminary data indeed reflects the effects of MANF ablation in the entire CNS, including
neurons and glial cells. It would be interesting and rewarding to delineate the contribution
of cell type (neuron or astrocyte) derived MANF on ethanol-induced neurodegeneration.
A better understanding of the role of MANF in ethanol-induced neurodegeneration may
reveal MANF as a critical player in ER stress regulation, thereby laying a foundation for
targeting MANF as a therapeutic approach in the treatment of FASDs or AUD.
6.3

MANF and Neurogenesis
In my third project, we have demonstrated that MANF deficiency promotes

neurogenesis in the SVZ and SGZ of the mouse brain by immunostaining of DCX and Ki67 as well as BrdU incorporation. Besides, we have shown that two crucial transcriptional
factors (NeuroD1 and Sox2) that are tightly linked with NSC multipotent and proliferative
capacities are increased in the brain of Manf cKO mice. Mechanistically, MANF was found
to inhibit cell cycle progression, which might be one of the mechanisms that underlie the
increase of neurogenesis in Manf cKO mice.
Neurogenesis was first reported to exist in the dentate gyrus of adult mouse brain
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decades ago [105]. It is now widely accepted that adult neurogenesis occurs at least in two
regions, i.e., subgranular zone and subventricular zone in humans and rodents [104, 106,
107]. MANF was first identified in an astrocyte cell line in search of astrocyte-derived
neurotrophic factor [91]. Subsequent studies found MANF is neuroprotective, especially
to dopaminergic neurons in vivo and in vitro [91, 96]. It has also been shown that MANF
is involved in neurite outgrowth and neuronal migration [95]. Mechanistically, MANF
promotes cell survival by interacting with proapoptotic proteins such as Bax and Bak to
prevent their proapoptotic properties or by promoting mTOR signaling to increase the
transcription of prosurvival genes [93, 94, 163]. As a neurotrophic factor, we reckoned that
MANF might participate in neurogenesis in the developing and mature mouse brain. As
opposed to our anticipation that MANF promotes neurogenesis, we observed an increase
of neurogenesis both in the SGZ and SVZ of Manf cKO mice. We think it may be because
MANF inhibits cell proliferative activity even though it promotes cell survival. Indeed,
numerous studies in cancer biology have reported that the gain-of-function of MANF
inhibits cell proliferation and reduces aggressive tumor properties [100, 164]. In light of
these reports and our data, we have examined a number of markers that are associated with
cell cycle progression. It turned out that MANF deficiency upregulates mitotic markers (pHH3 and cyclin A2) and meantime downregulates cell cycle inhibitors (p15 and p27).
Besides, we found the transcriptional factor, i.e., Sox2, is also upregulated in the brain of
Manf cKO mice. Sox2 has been reported to promote neurogenesis by repressing pathways
that promote cell quiescence such as p53 pathway and cell-cycle inhibitor p21 [165].
Collectively, all pieces of information, when assembled, seem to indicate that MANF
deficiency increases neurogenesis by promoting NSC proliferation.

88

While MANF ablation overall promotes neurogenesis in the mouse brain, it fails to
reactivate neurogenesis in aged mice. It has been reported that aging negatively regulates
neurogenesis manifested by a sharp and continuous decrease in cell population in both SGZ
and SVZ of the aged mouse brain [166, 167]. With aging, NSCs lose their proliferative
capability and become more quiescent even though some reports indicate that neurogenesis
can be reactivated to a certain extent in aged mice upon stimulation such as exercise or
calorie restriction [168, 169]. In humans, using postmortem and fresh tissues, scientists
have demonstrated that there is no evidence of neurogenesis in humans after adolescence
or there is a sharp decrease of neurogenesis with aging [170]. In summary, recent findings
point to the conclusion that neurogenesis is decreased with aging both in humans and
rodents. Our data is consistent with these reports showing that MANF ablation cannot
rejuvenate the quiescent NSCs that might or might not exist in aged mice. We speculate
that MANF may affect the process of neurogenesis, e.g., promote or inhibit neurogenesis,
but could not alter the intrinsic programs that underlie or determine NSC fate.
In summary, we have provided evidence showing that MANF affects neurogenesisthat is, MANF deficiency promotes neurogenesis in the mouse brain. With DCX staining
in the SGZ and Ki-67 in the SVZ as well as BrdU incorporation, we demonstrate that
neurogenesis is indeed increased in the brain of Manf cKO mice. Neurogenesis is a
complex process involving multiple developmental steps or stages characterized by cell
differentiation and lineage specification before they are integrated into neural circuitry. For
example, in the hippocampal dentate gyrus, mature granule neurons undergo at least three
developmental stages before they are functionally integrated into the hippocampal
circuitry. Type1 radial glia-like cells (RGLs) are thought to represent the NSCs population
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that possess self-renewal and multipotent capabilities. Intermediate progenitor cells (IPCs,
or type 2 cells) are believed to stem from RGL differentiation and possess transient
amplifying activities. IPC can differentiate into neuroblasts (type 3) that give rise to mature
granule dentate granule neurons [103]. It has been reported that DCX is expressed in
neuroblasts but not in RGL or IPC cells [102]. Therefore, it is unclear in which stage or
step MANF boosts neurogenesis in the hippocampal dentate gyrus. Likely, Ki-67 is a
general cell proliferation maker that can label any cells that are undergoing cell division
regardless of the specific stage of lineage differentiation. To decipher the regulatory role
of MANF in neurogenesis, the first and foremost important thing is to identify the particular
differential stages at which MANF regulates neurogenesis. Markers that are expressed at
specific stages of hippocampal neurogenesis and SVZ might be able to undertake this task.
In addition, MANF may affect neurogenesis through other signaling pathways such
as the metabolic pathway. Metabolic status has been suggested to be associated with stem
cell behavior or activity [103]. Inhibition of fatty acid synthesis through genetic or
pharmacological approaches can result in a decrease in stem cell proliferation [103]. A
recent study demonstrated that MANF is involved in energy metabolism by inducing
insulin resistance in the hypothalamus [99], which could directly or indirectly affect the
process of neurogenesis. Besides, although sharing no homology with another neurotrophic
factor, i.e., BDNF, MANF may also activate Trk receptor to stimulate stem cell growth or
maturation. A better understanding of the role of MANF in adult neurogenesis can enrich
our knowledge about neurogenesis, its regulation, and relevance to some neurological and
psychiatric diseases that are related to dysregulation of neurogenesis.
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6.4

Perspectives and Conclusions
It has been well established that ER stress is functionally linked with brain damage

[76]. Depending on diseases and the stimulant, the UPR triggered by ER stress may activate
different signaling components and consequently generate distinct outcomes. Initiated as a
protective mechanism, UPR induces the upregulation of a bunch of pro-survival factors to
maintain protein homeostasis. However, sustained activation of UPR may cause a shift
toward promoting cell damage during the symptomatic stage [76]. It still remains unclear
what factors, pathways or events mediate this functional shift of UPR from the constructive
role to the destructive role.
Ethanol exposure can induce ER stress both in the developing mouse brain and in
the adult mouse brain [115, 171]. It appears that ER stress contributes to ethanol-induced
neuronal death demonstrated by the employment of pharmacological approaches to
manipulate ER stress in cell culture. This finding is supported by the recent report showing
that ER stress also underlies ethanol-induced neuronal cell death in the developing brain
[116]. Ethanol exposure can downregulate mTOR signaling, which was previously
suggested to contribute to the induction of autophagy [150, 151]. While absent in
autophagy induction in our binge drinking animals, the downregulated mTOR signaling
seems to mediate the induction of ER stress (Figure 6). Therefore, depending on the ethanol
exposure paradigm and disease stages, mTOR signaling plays a critical role either in
promoting cell survival through the induction of autophagy or in triggering cell death
through the induction of ER stress. The underlying mechanisms behind this functional shift
of mTOR in the context of ethanol-induced neuronal death from preventing cell death to
favoring cell death remain to be determined.
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MANF has pleiotropic effects by participating in a multitude of biological
processes [95, 98, 99]. Located in the downstream of UPR signaling, MANF appears to
confer neuroprotective effects by preventing the overactivation of ER stress (Figure 6). The
exact mechanisms underlying this neuroprotective role remain unknown although multiple
mechanisms have been proposed. In our studies, MANF also exerts inhibitory effects on
neurogenesis, which is likely though retarding cell cycle progression (Figure 6). This
inhibitory effect of MANF on neurogenesis is intuitively contradictory to its
neuroprotective role. However, it is possible that the MANF-mediated cell cycle arrest, in
concert with its role in ER stress adaptation, renders beneficial effects on neuronal
plasticity. The temporary cell cycle arrest by MANF could be programmed intrinsically for
the cells to have enough time to fix ER stress and restore protein homeostasis (Figure 6).
Hence, MANF might have a dual role in neuroprotection and both are in a constructive
manner. In addition, given that MANF is induced by ethanol exposure [115, 116], the
inhibitory effects of MANF on neurogenesis might be also associated with the fact that
ethanol-induced intoxication can cause a decrease in neurogenesis in the vast majority of
cases. Future efforts are needed to systematically delineate the role of MANF-mediated
cell cycle alteration in neuronal plasticity modulation and its implication in ethanolmediated neurogenesis regulation.
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Figure 6. A Working Model for the Regulatory Network Involving mTOR, ER Stress
and MANF in Ethanol-induced Neurodegeneration. Ethanol exposure can cause a
sustained activation of ER stress that consequently results in neuronal cell death through
uncontrolled unfolded protein response. The downregulation of mTOR signaling by
ethanol mediates the induction of ER stress. MANF is neuroprotective against ethanolinduced neuronal death through ameliorating the overactivation of ER stress. MANF can
also retard cell cycle progression that consequently reduces neurogenesis.

93

REFERENCES
1.

2.

3.
4.

5.
6.

7.

8.

9.

10.

11.

National Institute on Alcohol Abuse and Alcoholism (NIAAA), What Is A Standard
Drink?
https://www.niaaa.nih.gov/alcohol-health/overview-alcoholconsumption/what-standard-drink.
National Institute on Alcohol Abuse and Alcoholism (NIAAA), Drinking Levels
Defined.
https://www.niaaa.nih.gov/alcohol-health/overview-alcoholconsumption/moderate-binge-drinking.
National Institute on Alcohol Abuse and Alcoholism (NIAAA), Alcohol Facts and
Statistics. https://www.niaaa.nih.gov/alcohol-facts-and-statistics.
World Health Organization (WHO), Global Status Report on Alcohol and Health
2018.
https://www.who.int/substance_abuse/publications/global_alcohol_report/en/.
National Institute on Alcohol Abuse and Alcoholism (NIAAA), Moderate
Drinking. https://pubs.niaaa.nih.gov/publications/aa16.htm.
SAMHSA, 2015 National Survey on Drug Use and Health (NSDUH). Table
2.41B—Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged
12 or Older, by Demographic Characteristics: Percentages, 2014 and 2015.
Available at: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs2015/NSDUH-DetTabs-2015/NSDUH-DetTabs-2015.htm#tab2-41b.
SAMHSA, 2015 National Survey on Drug Use and Health (NSDUH). Table
2.46B—Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month
among Persons Aged 12 or Older, by Demographic Characteristics: Percentages,
2014
and
2015.
Available
at:
https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUHDetTabs-2015/NSDUH-DetTabs-2015.htm#tab2-46b.
SAMHSA, 2015 National Survey on Drug Use and Health (NSDUH). Table
2.19B—Alcohol Use in Lifetime, Past Year, and Past Month, by Detailed Age
Category:
Percentages,
2014
and
2015.
Available
at:
https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUHDetTabs-2015/NSDUH-DetTabs-2015.htm#tab2-19b.
SAMHSA, 2015 Key Substance Use and Mental Health Indicators in the United
States: Results from the 2015 National Survey on Drug Use and Health. Figure 24.
Available at: https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR12015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.htm#fig24.
SAMHSA, 2015 National Survey on Drug Use and Health (NSDUH). Table
2.83B—Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in Past Month
among Persons Aged 12 to 20, by Demographic Characteristics: Percentages,
2014
and
2015.
Available
at:
https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUHDetTabs-2015/NSDUH-DetTabs-2015.htm#tab2-83b.
SAMHSA, 2015 National Survey on Drug Use and Health (NSDUH). Table
6.84B—Tobacco Product and Alcohol Use in Past Month among Persons Aged 18
to 22, by College Enrollment Status: Percentages, 2014 and 2015. Available at:
https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUHDetTabs-2015/NSDUH-DetTabs-2015.htm#tab6-84b.
94

12.
13.
14.

15.
16.
17.

18.
19.
20.
21.
22.

23.

24.
25.
26.

27.

28.
29.
30.
31.

Mokdad, A.H., et al., Actual causes of death in the United States, 2000. JAMA,
2004. 291(10): p. 1238-45.
National Institute on Alcohol Abuse and Alcoholism (NIAAA), Alcohol's Effects
on the Body.
Baliunas, D., et al., Alcohol consumption and risk of incident human
immunodeficiency virus infection: a meta-analysis. Int J Public Health, 2010. 55(3):
p. 159-66.
Reis, R.K., E.S. Melo, and E. Gir, Factors associated with inconsistent condom use
among people living with HIV/Aids. Rev Bras Enferm, 2016. 69(1): p. 40-6.
Gross, R., et al., Effects of sex and alcohol use on antiretroviral therapy outcomes
in Botswana: a cohort study. Addiction, 2017. 112(1): p. 73-81.
Neuman, M.G., et al., Alcohol Consumption, Progression of Disease and Other
Comorbidities, and Responses to Antiretroviral Medication in People Living with
HIV. AIDS Res Treat, 2012. 2012: p. 751827.
National Institute on Alcohol Abuse and Alcoholism (NIAAA), HIV/AIDS.
Laprawat, S., et al., Alcohol use disorder and tuberculosis treatment: A longitudinal
mixed method study in Thailand. S Afr J Psychiatr, 2017. 23: p. 1074.
Pande, J.N., et al., Risk factors for hepatotoxicity from antituberculosis drugs: a
case-control study. Thorax, 1996. 51(2): p. 132-6.
Volkmann, T., et al., Tuberculosis and excess alcohol use in the United States,
1997-2012. Int J Tuberc Lung Dis, 2015. 19(1): p. 111-9.
Roerecke, M. and J. Rehm, The cardioprotective association of average alcohol
consumption and ischaemic heart disease: a systematic review and meta-analysis.
Addiction, 2012. 107(7): p. 1246-60.
Briasoulis, A., V. Agarwal, and F.H. Messerli, Alcohol consumption and the risk of
hypertension in men and women: a systematic review and meta-analysis. J Clin
Hypertens (Greenwich), 2012. 14(11): p. 792-8.
Iacovoni, A., R. De Maria, and A. Gavazzi, Alcoholic cardiomyopathy. J
Cardiovasc Med (Hagerstown), 2010. 11(12): p. 884-92.
Kodama, S., et al., Alcohol consumption and risk of atrial fibrillation: a metaanalysis. J Am Coll Cardiol, 2011. 57(4): p. 427-36.
Patra, J., et al., Alcohol consumption and the risk of morbidity and mortality for
different stroke types--a systematic review and meta-analysis. BMC Public Health,
2010. 10: p. 258.
Roerecke, M. and J. Rehm, Irregular heavy drinking occasions and risk of ischemic
heart disease: a systematic review and meta-analysis. Am J Epidemiol, 2010.
171(6): p. 633-44.
Bagnardi, V., et al., Alcohol consumption and site-specific cancer risk: a
comprehensive dose-response meta-analysis. Br J Cancer, 2015. 112(3): p. 580-93.
Boffetta, P. and M. Hashibe, Alcohol and cancer. Lancet Oncol, 2006. 7(2): p. 14956.
Cao, Y., et al., Light to moderate intake of alcohol, drinking patterns, and risk of
cancer: results from two prospective US cohort studies. BMJ, 2015. 351: p. h4238.
Bruha, R., K. Dvorak, and J. Petrtyl, Alcoholic liver disease. World J Hepatol, 2012.
4(3): p. 81-90.

95

32.
33.
34.

35.

36.

37.
38.

39.
40.

41.

42.

43.

44.

45.

Gao, B. and R. Bataller, Alcoholic liver disease: pathogenesis and new therapeutic
targets. Gastroenterology, 2011. 141(5): p. 1572-85.
Duke, A.A., et al., Alcohol dose and aggression: another reason why drinking more
is a bad idea. J Stud Alcohol Drugs, 2011. 72(1): p. 34-43.
Giancola, P.R., et al., Alcohol Myopia Revisited: Clarifying Aggression and Other
Acts of Disinhibition Through a Distorted Lens. Perspect Psychol Sci, 2010. 5(3):
p. 265-78.
Hingson, R.W., W. Zha, and E.R. Weitzman, Magnitude of and trends in alcoholrelated mortality and morbidity among U.S. college students ages 18-24, 19982005. J Stud Alcohol Drugs Suppl, 2009(16): p. 12-20.
Hingson, R., et al., Magnitude of alcohol-related mortality and morbidity among
U.S. college students ages 18-24: changes from 1998 to 2001. Annu Rev Public
Health, 2005. 26: p. 259-79.
Crews, F.T. and K. Nixon, Mechanisms of neurodegeneration and regeneration in
alcoholism. Alcohol Alcohol, 2009. 44(2): p. 115-27.
Nardelli, A., et al., Extensive deep gray matter volume reductions in children and
adolescents with fetal alcohol spectrum disorders. Alcohol Clin Exp Res, 2011.
35(8): p. 1404-17.
Sullivan, E.V. and A. Pfefferbaum, Neurocircuitry in alcoholism: a substrate of
disruption and repair. Psychopharmacology (Berl), 2005. 180(4): p. 583-94.
Substance Abuse and Mental Health Services Administration (SAMHSA), 2015
National Survey on Drug Use and Health (NSDUH). Table 5.6A—Substance Use
Disorder in Past Year among Persons Aged 18 or Older, by Demographic
Characteristics: Numbers in Thousands, 2014 and 2015. Available at:
https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUHDetTabs-2015/NSDUH-DetTabs-2015.htm#tab5-6a.
Substance Abuse and Mental Health Services Administration (SAMHSA), 2015
National Survey on Drug Use and Health (NSDUH). Table 5.6B—Substance Use
Disorder in Past Year among Persons Aged 18 or Older, by Demographic
Characteristics:
Percentages,
2014
and
2015.
Available
at:
https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2015/NSDUHDetTabs-2015/NSDUH-DetTabs-2015.htm#tab5-6b.
Substance Abuse and Mental Health Services Administration (SAMHSA),
National Survey on Drug Use and Health (NSDUH). 2015 (NSDUH-2015-DS0001)
Public-Use File Dataset. Available at: https://www.datafiles.samhsa.gov/studydataset/national-survey-drug-use-and-health-2015-nsduh-2015-ds0001-nid16894.
Popova, S., et al., Estimation of national, regional, and global prevalence of
alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and
meta-analysis. Lancet Glob Health, 2017. 5(3): p. e290-e299.
May, P.A., et al., Prevalence and epidemiologic characteristics of FASD from
various research methods with an emphasis on recent in-school studies. Dev
Disabil Res Rev, 2009. 15(3): p. 176-92.
May, P.A., et al., Prevalence and characteristics of fetal alcohol syndrome and
partial fetal alcohol syndrome in a Rocky Mountain Region City. Drug Alcohol
Depend, 2015. 155: p. 118-27.

96

46.

47.

48.

49.
50.
51.
52.

53.
54.
55.

56.

57.

58.

59.

60.

61.
62.

Bonthius, D.J. and J.R. West, Alcohol-induced neuronal loss in developing rats:
increased brain damage with binge exposure. Alcohol Clin Exp Res, 1990. 14(1):
p. 107-18.
Collins, M.A., T.D. Corso, and E.J. Neafsey, Neuronal degeneration in rat
cerebrocortical and olfactory regions during subchronic "binge" intoxication with
ethanol: possible explanation for olfactory deficits in alcoholics. Alcohol Clin Exp
Res, 1996. 20(2): p. 284-92.
Crews, F.T., et al., Binge ethanol consumption causes differential brain damage in
young adolescent rats compared with adult rats. Alcohol Clin Exp Res, 2000.
24(11): p. 1712-23.
Ikonomidou, C., et al., Ethanol-induced apoptotic neurodegeneration and fetal
alcohol syndrome. Science, 2000. 287(5455): p. 1056-60.
Obernier, J.A., T.W. Bouldin, and F.T. Crews, Binge ethanol exposure in adult rats
causes necrotic cell death. Alcohol Clin Exp Res, 2002. 26(4): p. 547-57.
Saito, M., et al., Ethanol-Induced Neurodegeneration and Glial Activation in the
Developing Brain. Brain Sci, 2016. 6(3).
Bowden, S.C., et al., Neurotoxicity and neurocognitive impairments with alcohol
and drug-use disorders: potential roles in addiction and recovery. Alcohol Clin
Exp Res, 2001. 25(2): p. 317-21.
Kubota, M., et al., Alcohol consumption and frontal lobe shrinkage: study of 1432
non-alcoholic subjects. J Neurol Neurosurg Psychiatry, 2001. 71(1): p. 104-6.
Crews, F.T., et al., Alcohol-induced neurodegeneration: when, where and why?
Alcohol Clin Exp Res, 2004. 28(2): p. 350-64.
Pfefferbaum, A., et al., Longitudinal changes in magnetic resonance imaging brain
volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res, 1995. 19(5):
p. 1177-91.
Sullivan, E.V., M.J. Rosenbloom, and A. Pfefferbaum, Pattern of motor and
cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res, 2000. 24(5):
p. 611-21.
Prendergast, M.A., et al., In vitro effects of ethanol withdrawal and spermidine on
viability of hippocampus from male and female rat. Alcohol Clin Exp Res, 2000.
24(12): p. 1855-61.
Prendergast, M.A., et al., Hippocampal CA1 region neurodegeneration produced
by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal
pathways and function of N-methyl-D-aspartate receptors. Neuroscience, 2004.
124(4): p. 869-77.
Collins, M.A., J.Y. Zou, and E.J. Neafsey, Brain damage due to episodic alcohol
exposure in vivo and in vitro: furosemide neuroprotection implicates edema-based
mechanism. FASEB J, 1998. 12(2): p. 221-30.
Hamelink, C., et al., Comparison of cannabidiol, antioxidants, and diuretics in
reversing binge ethanol-induced neurotoxicity. J Pharmacol Exp Ther, 2005.
314(2): p. 780-8.
Parsons, O.A., Intellectual impairment in alcoholics: persistent issues. Acta Med
Scand Suppl, 1987. 717: p. 33-46.
Lucas, S.M., N.J. Rothwell, and R.M. Gibson, The role of inflammation in CNS
injury and disease. Br J Pharmacol, 2006. 147 Suppl 1: p. S232-40.
97

63.

64.

65.
66.

67.

68.

69.
70.
71.
72.

73.
74.
75.
76.
77.
78.
79.
80.

81.

Qin, L., et al., Increased systemic and brain cytokine production and
neuroinflammation
by
endotoxin
following
ethanol
treatment.
J
Neuroinflammation, 2008. 5: p. 10.
Qin, L. and F.T. Crews, NADPH oxidase and reactive oxygen species contribute to
alcohol-induced
microglial
activation
and
neurodegeneration.
J
Neuroinflammation, 2012. 9: p. 5.
Crews, F.T. and R.P. Vetreno, Mechanisms of neuroimmune gene induction in
alcoholism. Psychopharmacology (Berl), 2016. 233(9): p. 1543-57.
Ferrier, L., et al., Impairment of the intestinal barrier by ethanol involves enteric
microflora and mast cell activation in rodents. Am J Pathol, 2006. 168(4): p. 114854.
Guerri, C., C. Montoliu, and J. Renau-Piqueras, Involvement of free radical
mechanism in the toxic effects of alcohol: implications for fetal alcohol syndrome.
Adv Exp Med Biol, 1994. 366: p. 291-305.
Boyadjieva, N.I. and D.K. Sarkar, Microglia play a role in ethanol-induced
oxidative stress and apoptosis in developing hypothalamic neurons. Alcohol Clin
Exp Res, 2013. 37(2): p. 252-62.
Haorah, J., et al., Mechanism of alcohol-induced oxidative stress and neuronal
injury. Free Radic Biol Med, 2008. 45(11): p. 1542-50.
Wang, X., et al., Cdc42-dependent activation of NADPH oxidase is involved in
ethanol-induced neuronal oxidative stress. PLoS One, 2012. 7(5): p. e38075.
Morgan, M.J. and Z.G. Liu, Crosstalk of reactive oxygen species and NF-kappaB
signaling. Cell Res, 2011. 21(1): p. 103-15.
Kratsovnik, E., et al., Oxidative stress activates transcription factor NF-kBmediated protective signaling in primary rat neuronal cultures. J Mol Neurosci,
2005. 26(1): p. 27-32.
Kaushik, S. and A.M. Cuervo, Proteostasis and aging. Nat Med, 2015. 21(12): p.
1406-15.
Ron, D., Translational control in the endoplasmic reticulum stress response. J Clin
Invest, 2002. 110(10): p. 1383-8.
Marciniak, S.J. and D. Ron, Endoplasmic reticulum stress signaling in disease.
Physiol Rev, 2006. 86(4): p. 1133-49.
Hetz, C. and S. Saxena, ER stress and the unfolded protein response in
neurodegeneration. Nat Rev Neurol, 2017. 13(8): p. 477-491.
Aguzzi, A. and T. O'Connor, Protein aggregation diseases: pathogenicity and
therapeutic perspectives. Nat Rev Drug Discov, 2010. 9(3): p. 237-48.
Wang, L., B. Popko, and R.P. Roos, The unfolded protein response in familial
amyotrophic lateral sclerosis. Hum Mol Genet, 2011. 20(5): p. 1008-15.
Das, I., et al., Preventing proteostasis diseases by selective inhibition of a
phosphatase regulatory subunit. Science, 2015. 348(6231): p. 239-42.
Wang, L., B. Popko, and R.P. Roos, An enhanced integrated stress response
ameliorates mutant SOD1-induced ALS. Hum Mol Genet, 2014. 23(10): p. 262938.
Moreno, J.A., et al., Sustained translational repression by eIF2alpha-P mediates
prion neurodegeneration. Nature, 2012. 485(7399): p. 507-11.

98

82.

83.
84.
85.

86.
87.
88.
89.

90.

91.

92.

93.

94.
95.
96.

97.
98.
99.
100.

Kubisch, C.H., et al., Early activation of endoplasmic reticulum stress is associated
with arginine-induced acute pancreatitis. Am J Physiol Gastrointest Liver Physiol,
2006. 291(2): p. G238-45.
Pandol, S.J., et al., Alcohol abuse, endoplasmic reticulum stress and pancreatitis.
Dig Dis, 2010. 28(6): p. 776-82.
Lugea, A., et al., Adaptive unfolded protein response attenuates alcohol-induced
pancreatic damage. Gastroenterology, 2011. 140(3): p. 987-97.
Ji, C., et al., Liver-specific loss of glucose-regulated protein 78 perturbs the
unfolded protein response and exacerbates a spectrum of liver diseases in mice.
Hepatology, 2011. 54(1): p. 229-39.
Ji, C. and N. Kaplowitz, ER stress: can the liver cope? J Hepatol, 2006. 45(2): p.
321-33.
Dara, L., C. Ji, and N. Kaplowitz, The contribution of endoplasmic reticulum stress
to liver diseases. Hepatology, 2011. 53(5): p. 1752-63.
Ji, C., et al., Role of CHOP in hepatic apoptosis in the murine model of intragastric
ethanol feeding. Alcohol Clin Exp Res, 2005. 29(8): p. 1496-503.
Li, S.Y. and J. Ren, Cardiac overexpression of alcohol dehydrogenase exacerbates
chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role
of insulin signaling and ER stress. J Mol Cell Cardiol, 2008. 44(6): p. 992-1001.
Li, S.Y., et al., Aldehyde dehydrogenase-2 (ALDH2) ameliorates chronic alcohol
ingestion-induced myocardial insulin resistance and endoplasmic reticulum stress.
J Mol Cell Cardiol, 2009. 47(2): p. 247-55.
Petrova, P., et al., MANF: a new mesencephalic, astrocyte-derived neurotrophic
factor with selectivity for dopaminergic neurons. J Mol Neurosci, 2003. 20(2): p.
173-88.
Lindholm, P., et al., MANF is widely expressed in mammalian tissues and
differently regulated after ischemic and epileptic insults in rodent brain. Mol Cell
Neurosci, 2008. 39(3): p. 356-71.
Hellman, M., et al., Mesencephalic astrocyte-derived neurotrophic factor (MANF)
has a unique mechanism to rescue apoptotic neurons. J Biol Chem, 2011. 286(4):
p. 2675-80.
Hoseki, J., et al., Solution structure and dynamics of mouse ARMET. FEBS Lett,
2010. 584(8): p. 1536-42.
Tseng, K.Y., et al., MANF Is Essential for Neurite Extension and Neuronal
Migration in the Developing Cortex. eNeuro, 2017. 4(5).
Voutilainen, M.H., et al., Mesencephalic astrocyte-derived neurotrophic factor is
neurorestorative in rat model of Parkinson's disease. J Neurosci, 2009. 29(30): p.
9651-9.
Lindholm, P. and M. Saarma, Novel CDNF/MANF family of neurotrophic factors.
Dev Neurobiol, 2010. 70(5): p. 360-71.
Neves, J., et al., Immune modulation by MANF promotes tissue repair and
regenerative success in the retina. Science, 2016. 353(6294): p. aaf3646.
Yang, S., et al., MANF regulates hypothalamic control of food intake and body
weight. Nat Commun, 2017. 8(1): p. 579.
Apostolou, A., et al., Armet, a UPR-upregulated protein, inhibits cell proliferation
and ER stress-induced cell death. Exp Cell Res, 2008. 314(13): p. 2454-67.
99

101.

102.
103.
104.
105.
106.
107.
108.
109.
110.

111.

112.
113.

114.
115.
116.
117.
118.

119.
120.

Yu, Y.Q., et al., Induction profile of MANF/ARMET by cerebral ischemia and its
implication for neuron protection. J Cereb Blood Flow Metab, 2010. 30(1): p. 7991.
Zhao, C., W. Deng, and F.H. Gage, Mechanisms and functional implications of
adult neurogenesis. Cell, 2008. 132(4): p. 645-60.
Goncalves, J.T., S.T. Schafer, and F.H. Gage, Adult Neurogenesis in the
Hippocampus: From Stem Cells to Behavior. Cell, 2016. 167(4): p. 897-914.
Crews, F.T. and K. Nixon, Alcohol, neural stem cells, and adult neurogenesis.
Alcohol Res Health, 2003. 27(2): p. 197-204.
Altman, J. and G.D. Das, Autoradiographic and histological evidence of postnatal
hippocampal neurogenesis in rats. J Comp Neurol, 1965. 124(3): p. 319-35.
Eriksson, P.S., et al., Neurogenesis in the adult human hippocampus. Nat Med,
1998. 4(11): p. 1313-7.
Spalding, K.L., et al., Dynamics of hippocampal neurogenesis in adult humans.
Cell, 2013. 153(6): p. 1219-1227.
Geil, C.R., et al., Alcohol and adult hippocampal neurogenesis: promiscuous drug,
wanton effects. Prog Neuropsychopharmacol Biol Psychiatry, 2014. 54: p. 103-13.
Nixon, K. and F.T. Crews, Binge ethanol exposure decreases neurogenesis in adult
rat hippocampus. J Neurochem, 2002. 83(5): p. 1087-93.
Anderson, M.L., et al., Moderate drinking? Alcohol consumption significantly
decreases neurogenesis in the adult hippocampus. Neuroscience, 2012. 224: p.
202-9.
Aberg, E., et al., Moderate ethanol consumption increases hippocampal cell
proliferation and neurogenesis in the adult mouse. Int J Neuropsychopharmacol,
2005. 8(4): p. 557-67.
Pawlak, R., et al., Ethanol-induced neurotoxicity is counterbalanced by increased
cell proliferation in mouse dentate gyrus. Neurosci Lett, 2002. 327(2): p. 83-6.
Herrera, D.G., et al., Selective impairment of hippocampal neurogenesis by chronic
alcoholism: protective effects of an antioxidant. Proc Natl Acad Sci U S A, 2003.
100(13): p. 7919-24.
Chen, G., et al., Ethanol promotes endoplasmic reticulum stress-induced neuronal
death: involvement of oxidative stress. J Neurosci Res, 2008. 86(4): p. 937-46.
Ke, Z., et al., Ethanol induces endoplasmic reticulum stress in the developing brain.
Alcohol Clin Exp Res, 2011. 35(9): p. 1574-83.
Li, H., et al., 4-Phenylbutyric Acid Protects Against Ethanol-Induced Damage in
the Developing Mouse Brain. Alcohol Clin Exp Res, 2019. 43(1): p. 69-78.
Schmued, L.C., et al., Fluoro-Jade C results in ultra high resolution and contrast
labeling of degenerating neurons. Brain Res, 2005. 1035(1): p. 24-31.
Lehner, B., et al., The dark side of BrdU in neural stem cell biology: detrimental
effects on cell cycle, differentiation and survival. Cell Tissue Res, 2011. 345(3): p.
313-28.
Hoshino, T., et al., Cell kinetic studies of in situ human brain tumors with
bromodeoxyuridine. Cytometry, 1985. 6(6): p. 627-32.
Mandyam, C.D., G.C. Harburg, and A.J. Eisch, Determination of key aspects of
precursor cell proliferation, cell cycle length and kinetics in the adult mouse
subgranular zone. Neuroscience, 2007. 146(1): p. 108-22.
100

121.
122.
123.

124.

125.
126.

127.
128.
129.
130.
131.

132.

133.
134.

135.
136.
137.
138.

139.

Chen, G., et al., Autophagy is a protective response to ethanol neurotoxicity.
Autophagy, 2012. 8(11): p. 1577-89.
Kim, I.M., et al., beta-arrestin1-biased beta1-adrenergic receptor signaling
regulates microRNA processing. Circ Res, 2014. 114(5): p. 833-44.
Ji, Z., et al., Binge Alcohol Exposure Causes Neurobehavioral Deficits and
GSK3beta Activation in the Hippocampus of Adolescent Rats. Sci Rep, 2018. 8(1):
p. 3088.
Zhang, Z., et al., Dose- and time-dependent expression of anxiety-like behavior in
the elevated plus-maze during withdrawal from acute and repeated intermittent
ethanol intoxication in rats. Alcohol Clin Exp Res, 2007. 31(11): p. 1811-9.
Li, B. and C.N. Dewey, RSEM: accurate transcript quantification from RNA-Seq
data with or without a reference genome. BMC Bioinformatics, 2011. 12: p. 323.
Leng, N., et al., EBSeq-HMM: a Bayesian approach for identifying geneexpression changes in ordered RNA-seq experiments. Bioinformatics, 2015.
31(16): p. 2614-22.
Kuleshov, M.V., et al., Enrichr: a comprehensive gene set enrichment analysis web
server 2016 update. Nucleic Acids Res, 2016. 44(W1): p. W90-7.
Xu, M., et al., Role of MCP-1 in alcohol-induced aggressiveness of colorectal
cancer cells. Mol Carcinog, 2016. 55(5): p. 1002-11.
Nakagawa, T., et al., Caspase-12 mediates endoplasmic-reticulum-specific
apoptosis and cytotoxicity by amyloid-beta. Nature, 2000. 403(6765): p. 98-103.
Block, M.L. and J.S. Hong, Chronic microglial activation and progressive
dopaminergic neurotoxicity. Biochem Soc Trans, 2007. 35(Pt 5): p. 1127-32.
Appenzeller-Herzog, C. and M.N. Hall, Bidirectional crosstalk between
endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol, 2012. 22(5):
p. 274-82.
Tadimalla, A., et al., Mesencephalic astrocyte-derived neurotrophic factor is an
ischemia-inducible secreted endoplasmic reticulum stress response protein in the
heart. Circ Res, 2008. 103(11): p. 1249-58.
Olney, J.W., et al., Ethanol-induced apoptotic neurodegeneration in the developing
C57BL/6 mouse brain. Brain Res Dev Brain Res, 2002. 133(2): p. 115-26.
Vukovic, J., et al., Immature doublecortin-positive hippocampal neurons are
important for learning but not for remembering. J Neurosci, 2013. 33(15): p. 660313.
Kee, N., et al., The utility of Ki-67 and BrdU as proliferative markers of adult
neurogenesis. J Neurosci Methods, 2002. 115(1): p. 97-105.
Cartlidge, D. and A.D. Redmond, Alcohol and conscious level. Biomed
Pharmacother, 1990. 44(4): p. 205-8.
Jones, A.W., The drunkest drinking driver in Sweden: blood alcohol concentration
0.545% w/v. J Stud Alcohol, 1999. 60(3): p. 400-6.
van Hoof, J.J., et al., Adolescent alcohol intoxication in the Dutch hospital
departments of pediatrics: a 2-year comparison study. J Adolesc Health, 2011.
48(2): p. 212-4.
Jones, A.W. and P. Harding, Driving under the influence with blood alcohol
concentrations over 0.4 g%. Forensic Sci Int, 2013. 231(1-3): p. 349-53.

101

140.

141.
142.

143.

144.

145.

146.
147.

148.

149.

150.
151.

152.

153.

154.
155.

Kane, C.J., et al., Effects of ethanol on immune response in the brain: regionspecific changes in adolescent versus adult mice. Alcohol Clin Exp Res, 2014.
38(2): p. 384-91.
Lovinger, D.M., Excitotoxicity and alcohol-related brain damage. Alcohol Clin
Exp Res, 1993. 17(1): p. 19-27.
Zou, J. and F. Crews, Induction of innate immune gene expression cascades in brain
slice cultures by ethanol: key role of NF-kappaB and proinflammatory cytokines.
Alcohol Clin Exp Res, 2010. 34(5): p. 777-89.
Shiraishi, H., et al., ER stress-induced apoptosis and caspase-12 activation occurs
downstream of mitochondrial apoptosis involving Apaf-1. J Cell Sci, 2006. 119(Pt
19): p. 3958-66.
Kerbiriou, M., et al., The calpain, caspase 12, caspase 3 cascade leading to
apoptosis is altered in F508del-CFTR expressing cells. PLoS One, 2009. 4(12): p.
e8436.
Morishima, N., et al., An endoplasmic reticulum stress-specific caspase cascade in
apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol
Chem, 2002. 277(37): p. 34287-94.
Ji, C., Mechanisms of alcohol-induced endoplasmic reticulum stress and organ
injuries. Biochem Res Int, 2012. 2012: p. 216450.
Clayton, B.L.L. and B. Popko, Endoplasmic reticulum stress and the unfolded
protein response in disorders of myelinating glia. Brain Res, 2016. 1648(Pt B): p.
594-602.
Lin, W., et al., Oligodendrocyte-specific activation of PERK signaling protects
mice against experimental autoimmune encephalomyelitis. J Neurosci, 2013.
33(14): p. 5980-91.
Patel, S., et al., Crosstalk between endoplasmic reticulum stress and oxidative
stress in schizophrenia: The dawn of new therapeutic approaches. Neurosci
Biobehav Rev, 2017.
Luo, J., Autophagy and ethanol neurotoxicity. Autophagy, 2014. 10(12): p. 2099108.
Pla, A., M. Pascual, and C. Guerri, Autophagy Constitutes a Protective Mechanism
against Ethanol Toxicity in Mouse Astrocytes and Neurons. PLoS One, 2016. 11(4):
p. e0153097.
Morris, S.A., et al., Alcohol inhibition of neurogenesis: a mechanism of
hippocampal neurodegeneration in an adolescent alcohol abuse model.
Hippocampus, 2010. 20(5): p. 596-607.
Nixon, K. and F.T. Crews, Temporally specific burst in cell proliferation increases
hippocampal neurogenesis in protracted abstinence from alcohol. J Neurosci,
2004. 24(43): p. 9714-22.
Obernier, J.A., et al., Cognitive deficits and CNS damage after a 4-day binge
ethanol exposure in rats. Pharmacol Biochem Behav, 2002. 72(3): p. 521-32.
Thomas, J.D., et al., Behavioral deficits induced by bingelike exposure to alcohol
in neonatal rats: importance of developmental timing and number of episodes. Dev
Psychobiol, 1996. 29(5): p. 433-52.

102

156.

157.

158.
159.

160.
161.
162.

163.

164.

165.
166.

167.

168.

169.

170.
171.

Taffe, M.A., et al., Long-lasting reduction in hippocampal neurogenesis by alcohol
consumption in adolescent nonhuman primates. Proc Natl Acad Sci U S A, 2010.
107(24): p. 11104-9.
Semple, B.D., et al., Brain development in rodents and humans: Identifying
benchmarks of maturation and vulnerability to injury across species. Prog
Neurobiol, 2013. 106-107: p. 1-16.
Yan, Y., et al., MANF antagonizes nucleotide exchange by the endoplasmic
reticulum chaperone BiP. Nat Commun, 2019. 10(1): p. 541.
Arrieta, A., et al., MANF, a structurally unique redox-sensitive chaperone, restores
ER-protein folding in the ischemic heart. Journal of Molecular and Cellular
Cardiology, 2017. 112: p. 165.
Nagahama, M., et al., UBXD1 is a VCP-interacting protein that is involved in ERassociated degradation. Biochem Biophys Res Commun, 2009. 382(2): p. 303-8.
Wang, X., et al., Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated
degradation substrates. J Cell Biol, 2009. 187(5): p. 655-68.
Henderson, M.J., et al., Mesencephalic astrocyte-derived neurotrophic factor
(MANF) secretion and cell surface binding are modulated by KDEL receptors. J
Biol Chem, 2013. 288(6): p. 4209-25.
Tseng, K.Y., et al., MANF Promotes Differentiation and Migration of Neural
Progenitor Cells with Potential Neural Regenerative Effects in Stroke. Mol Ther,
2018. 26(1): p. 238-255.
Liu, J., et al., MANF inhibits liver cancer via SUMOylation-related suppression of
NF-kappaB/Snail signaling pathway and epithelial-mesenchymal transition.
Hepatology, 2019.
Niu, W., et al., Activation of postnatal neural stem cells requires nuclear receptor
TLX. J Neurosci, 2011. 31(39): p. 13816-28.
Kuhn, H.G., H. Dickinson-Anson, and F.H. Gage, Neurogenesis in the dentate
gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J
Neurosci, 1996. 16(6): p. 2027-33.
Encinas, J.M., et al., Division-coupled astrocytic differentiation and age-related
depletion of neural stem cells in the adult hippocampus. Cell Stem Cell, 2011. 8(5):
p. 566-79.
Bouab, M., et al., Aging of the subventricular zone neural stem cell niche: evidence
for quiescence-associated changes between early and mid-adulthood.
Neuroscience, 2011. 173: p. 135-49.
Lugert, S., et al., Quiescent and active hippocampal neural stem cells with distinct
morphologies respond selectively to physiological and pathological stimuli and
aging. Cell Stem Cell, 2010. 6(5): p. 445-56.
Sorrells, S.F., et al., Human hippocampal neurogenesis drops sharply in children
to undetectable levels in adults. Nature, 2018. 555(7696): p. 377-381.
Wang, Y., et al., Binge ethanol exposure induces endoplasmic reticulum stress in
the brain of adult mice. Toxicol Appl Pharmacol, 2018. 356: p. 172-181.

103

VITA
Yongchao Wang
EDUCATION
Nanjing University, Nanjing, China
M.S. in Biochemistry and Molecular Biology
Thesis: Analysis of the Effects of Disruption of Pepsin-like Proteases
in Aspergillus Niger on Heterogeneous Laccase Expression
China Pharmaceutical University, Nanjing, China
B.S. in Pharmaceutical Analysis
PROFESSIONAL EXPERIENCE
University of Kentucky, Lexington, KY
Graduate Research Assistant
Augusta University, Augusta, GA
Research Associate

2005

2002

2014-2019
2006-2014

HONORS AND AWARDS
2019, Student Travel Award, 42nd Annual RSA Scientific Meeting, Minneapolis, MN.
2018, Student Travel Award, 41st Annual RSA Scientific Meeting, San Diego, CA.
2017-2018, T32 Training Grant, NIH
2017, Travel Award, Purdue University Biomolecular Galaxy Symposium, Purdue, IN.
2002-2005, Graduate Scholarship, Nanjing University, China
1998-2002, Second-class Scholarship, China Pharmaceutical University, China
PUBLICATIONS
1.

2.

3.

Xu M, Wang S, Wang Y, Wu H, Frank JA, Zhang Z, Luo J. Role of p38γ MAPK in
regulation of EMT and cancer stem cells. Biochim Biophys Acta Mol Basis Dis. 2018
Nov;1864(11):3605-3617. doi: 10.1016/j.bbadis.2018.08.024. Epub 2018 Aug 18.
PubMed PMID: 30251680; PubMed Central PMCID: PMC6428452.
Wang Y, Wang X, Li H, Xu M, Frank J, Luo J. Binge ethanol exposure induces
endoplasmic reticulum stress in the brain of adult mice. Toxicol Appl Pharmacol.
2018 Oct 1;356:172-181. doi: 10.1016/j.taap.2018.08.006. Epub 2018 Aug 13.
PubMed PMID: 30114398; PubMed Central PMCID: PMC6258015.
Bayoumi AS, Park KM, Wang Y, Teoh JP, Aonuma T, Tang Y, Su H, Weintraub
NL, Kim IM. A carvedilol-responsive microRNA, miR-125b-5p protects the heart
from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in
cardiomyocytes.
J
Mol Cell
Cardiol.
2018 Jan;114:72-82. doi:
10.1016/j.yjmcc.2017.11.003. Epub 2017 Nov 7. PubMed PMID: 29122578;
PubMed Central PMCID: PMC5800989.

104

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

Zhu X, Hu T, Ho MH, Wang Y, Yu M, Patel N, Pi W, Choi JH, Xu H, Ganapathy
V, Kutlar F, Kutlar A, Tuan D. Hydroxyurea differentially modulates activator and
repressors of γ-globin gene in erythroblasts of responsive and non-responsive
patients with sickle cell disease in correlation with Index of Hydroxyurea
Responsiveness.
Haematologica.
2017
Dec;102(12):1995-2004.
doi:
10.3324/haematol.2017.175646. Epub 2017 Sep 29. PubMed PMID: 28971909;
PubMed Central PMCID: PMC5709098.
Wang Y, Xu M, Ke ZJ, Luo J. Cellular and molecular mechanisms underlying
alcohol-induced aggressiveness of breast cancer. Pharmacol Res. 2017 Jan;115:299308. doi: 10.1016/j.phrs.2016.12.005. Epub 2016 Dec 8. Review. PubMed PMID:
27939360; PubMed Central PMCID: PMC5205572.
Ren Z, Yang F, Wang X, Wang Y, Xu M, Frank JA, Ke ZJ, Zhang Z, Shi X, Luo J.
Chronic plus binge ethanol exposure causes more severe pancreatic injury and
inflammation. Toxicol Appl Pharmacol. 2016 Oct 1;308:11-19. doi:
10.1016/j.taap.2016.08.012. Epub 2016 Aug 15. PubMed PMID: 27538709;
PubMed Central PMCID: PMC5023495.
Park KM, Teoh JP, Wang Y, Broskova Z, Bayoumi AS, Tang Y, Su H, Weintraub
NL, Kim IM. Carvedilol-responsive microRNAs, miR-199a-3p and -214 protect
cardiomyocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart
Circ Physiol. 2016 Aug 1;311(2):H371-83. doi: 10.1152/ajpheart.00807.2015. Epub
2016 Jun 10. PubMed PMID: 27288437; PubMed Central PMCID: PMC5005281.
Tang Y, Wang Y, Park KM, Hu Q, Teoh JP, Broskova Z, Ranganathan P, Jayakumar
C, Li J, Su H, Tang Y, Ramesh G, Kim IM. MicroRNA-150 protects the mouse heart
from ischaemic injury by regulating cell death. Cardiovasc Res. 2015 Jun
1;106(3):387-97. doi: 10.1093/cvr/cvv121. Epub 2015 Mar 30. PubMed PMID:
25824147; PubMed Central PMCID: PMC4447807.
Teoh JP, Park KM, Wang Y, Hu Q, Kim S, Wu G, Huang S, Maihle N, Kim IM.
Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in
modulating human ovarian cancer cell tumorigenesis. Cell Signal. 2014
Dec;26(12):2885-95. doi: 10.1016/j.cellsig.2014.08.024. Epub 2014 Sep 3. PubMed
PMID: 25194819; PubMed Central PMCID: PMC4254323.
Wang Y, Kim S, Kim IM. Regulation of Metastasis by microRNAs in Ovarian
Cancer. Front Oncol. 2014;4:143. doi: 10.3389/fonc.2014.00143. eCollection 2014.
Review. PubMed PMID: 24959422; PubMed Central PMCID: PMC4050529.
Kim IM, Wang Y, Park KM, Tang Y, Teoh JP, Vinson J, Traynham CJ, Pironti G,
Mao L, Su H, Johnson JA, Koch WJ, Rockman HA. β-arrestin1-biased β1-adrenergic
receptor signaling regulates microRNA processing. Circ Res. 2014 Feb
28;114(5):833-44. doi: 10.1161/CIRCRESAHA.114.302766. Epub 2013 Dec 13.
PubMed PMID: 24334028; PubMed Central PMCID: PMC3955054.
Neal C, Teoh J, Tang Y, Wang Y, Park K, Kim I. MicroRNAs as
DiagnostiPrognostic and Predictive Biomarkers of Ovarian Cancer. Recent Patents
on Biomarkers. 2013 August; 3(2):120-136. doi: 10.2174/2210309011303030004.
Wang Y, Teoh J, Park K, Tang Y, Krothapalli S, Su H, Kim I. MicroRNAs as
diagnostic, prognostic and predictive biomarkers of cardiac disease. Recent Patents
on Biomarkers. 2013; 3(2):81-97.

105

14. Zhu X, Wang Y, Pi W, Liu H, Wickrema A, Tuan D. NF-Y recruits both
transcription activator and repressor to modulate tissue- and developmental stagespecific expression of human γ-globin gene. PLoS One. 2012;7(10):e47175. doi:
10.1371/journal.pone.0047175. Epub 2012 Oct 10. PubMed PMID: 23071749;
PubMed Central PMCID: PMC3468502.
15. Pi W, Zhu X, Wu M, Wang Y, Fulzele S, Eroglu A, Ling J, Tuan D. Long-range
function of an intergenic retrotransposon. Proc Natl Acad Sci U S A. 2010 Jul
20;107(29):12992-7. doi: 10.1073/pnas.1004139107. Epub 2010 Jul 6. PubMed
PMID: 20615953; PubMed Central PMCID: PMC2919959.
16. Wang Y, Fiskus W, Chong DG, Buckley KM, Natarajan K, Rao R, Joshi A, Balusu
R, Koul S, Chen J, Savoie A, Ustun C, Jillella AP, Atadja P, Levine RL, Bhalla KN.
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates
JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against
human myeloproliferative neoplastic cells. Blood. 2009 Dec 3;114(24):5024-33. doi:
10.1182/blood-2009-05-222133. Epub 2009 Oct 14. PubMed PMID: 19828702;
PubMed Central PMCID: PMC2788976.
17. Fiskus W, Wang Y, Sreekumar A, Buckley KM, Shi H, Jillella A, Ustun C, Rao R,
Fernandez P, Chen J, Balusu R, Koul S, Atadja P, Marquez VE, Bhalla KN.
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human
AML cells. Blood. 2009 Sep 24;114(13):2733-43. doi: 10.1182/blood-2009-03213496. Epub 2009 Jul 28. PubMed PMID: 19638619; PubMed Central PMCID:
PMC2756128.
18. Rao R, Lee P, Fiskus W, Yang Y, Joshi R, Wang Y, Buckley K, Balusu R, Chen J,
Koul S, Joshi A, Upadhyay S, Tao J, Sotomayor E, Bhalla KN. Co-treatment with
heat
shock
protein
90
inhibitor
17-dimethylaminoethylamino-17demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination
against human mantle cell lymphoma (MCL) cells. Cancer Biol Ther. 2009
Jul;8(13):1273-80. doi: 10.4161/cbt.8.13.8726. PubMed PMID: 19440035; PubMed
Central PMCID: PMC2766923.
19. Fiskus W, Buckley K, Rao R, Mandawat A, Yang Y, Joshi R, Wang Y, Balusu R,
Chen J, Koul S, Joshi A, Upadhyay S, Atadja P, Bhalla KN. Panobinostat treatment
depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression
of JunB and loss of survival of human acute leukemia cells. Cancer Biol Ther. 2009
May;8(10):939-50. doi: 10.4161/cbt.8.10.8213. Epub 2009 May 18. PubMed PMID:
19279403; PubMed Central PMCID: PMC2775142.
20. Chen J, Fiskus W, Eaton K, Fernandez P, Wang Y, Rao R, Lee P, Joshi R, Yang Y,
Kolhe R, Balusu R, Chappa P, Natarajan K, Jillella A, Atadja P, Bhalla KN.
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal
action of HDAC7-Nur77-based mechanism. Blood. 2009 Apr 23;113(17):4038-48.
doi: 10.1182/blood-2008-08-176024. Epub 2008 Dec 12. PubMed PMID: 19074726.
21. Fiskus W, Rao R, Fernandez P, Herger B, Yang Y, Chen J, Kolhe R, Mandawat A,
Wang Y, Joshi R, Eaton K, Lee P, Atadja P, Peiper S, Bhalla K. Molecular and
biologic characterization and drug sensitivity of pan-histone deacetylase inhibitorresistant acute myeloid leukemia cells. Blood. 2008 Oct 1;112(7):2896-905. doi:
10.1182/blood-2007-10-116319. Epub 2008 Jul 25. PubMed PMID: 18660379.
106

22. Fiskus W, Wang Y, Joshi R, Rao R, Yang Y, Chen J, Kolhe R, Balusu R, Eaton K,
Lee P, Ustun C, Jillella A, Buser CA, Peiper S, Bhalla K. Cotreatment with vorinostat
enhances activity of MK-0457 (VX-680) against acute and chronic myelogenous
leukemia cells. Clin Cancer Res. 2008 Oct 1;14(19):6106-15. doi: 10.1158/10780432.CCR-08-0721. PubMed PMID: 18829489; PubMed Central PMCID:
PMC2665710.
23. Wang Y, Xue W, Sims AH, Zhao C, Wang A, Tang G, Qin J, Wang H. Isolation of
four pepsin-like protease genes from Aspergillus niger and analysis of the effect of
disruptions on heterologous laccase expression. Fungal Genet Biol. 2008
Jan;45(1):17-27. doi: 10.1016/j.fgb.2007.09.012. Epub 2007 Sep 29. PubMed PMID:
17977034.
24. Wang Y, Qin J, Wang A, Tang G, Wang H. Construction and functional analysis of
the mnn9 gene disruption mutant in Aspergillus niger. Mycosystema. 2006;
15(1):70-76.

107

